<SEC-DOCUMENT>0001213900-22-021955.txt : 20220427
<SEC-HEADER>0001213900-22-021955.hdr.sgml : 20220427
<ACCEPTANCE-DATETIME>20220427164507
ACCESSION NUMBER:		0001213900-22-021955
CONFORMED SUBMISSION TYPE:	DEF 14A
PUBLIC DOCUMENT COUNT:		3
CONFORMED PERIOD OF REPORT:	20220608
FILED AS OF DATE:		20220427
DATE AS OF CHANGE:		20220427

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Lantern Pharma Inc.
		CENTRAL INDEX KEY:			0001763950
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				463973463
		STATE OF INCORPORATION:			TX
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		DEF 14A
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-39318
		FILM NUMBER:		22860482

	BUSINESS ADDRESS:	
		STREET 1:		1920 MCKINNEY AVENUE
		STREET 2:		7TH FLOOR
		CITY:			DALLAS
		STATE:			TX
		ZIP:			75201
		BUSINESS PHONE:		972-277-1136

	MAIL ADDRESS:	
		STREET 1:		1920 MCKINNEY AVENUE
		STREET 2:		7TH FLOOR
		CITY:			DALLAS
		STATE:			TX
		ZIP:			75201

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Lantern Pharma
		DATE OF NAME CHANGE:	20190108
</SEC-HEADER>
<DOCUMENT>
<TYPE>DEF 14A
<SEQUENCE>1
<FILENAME>ea158784-def14a_lantern.htm
<DESCRIPTION>DEFINITIVE PROXY STATEMENT
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif"></FONT></P>

<!-- Field: Rule-Page --><DIV STYLE="margin-top: 0; margin-bottom: 0; width: 100%"><DIV STYLE="font-size: 1pt; border-top: Black 2pt solid; border-bottom: Black 1pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">United
States<BR>
Securities and Exchange Commission<BR>
Washington, D.C. 20549</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>

<!-- Field: Rule-Page --><DIV STYLE="margin-left: auto; margin-right: auto; width: 25%"><DIV STYLE="font-size: 1pt; border-top: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">SCHEDULE
14A INFORMATION</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>

<!-- Field: Rule-Page --><DIV STYLE="margin-left: auto; margin-right: auto; width: 25%"><DIV STYLE="font-size: 1pt; border-top: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">PROXY
STATEMENT PURSUANT TO SECTION 14(A) OF<BR>
THE SECURITIES EXCHANGE ACT OF 1934</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 35%; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Filed by Registrant</FONT></TD>
    <TD STYLE="width: 65%; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9746;</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Filed by a Party other than
    the Registrant</FONT></TD>
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9744;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Check
the appropriate box:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#9744;</FONT></TD><TD STYLE="text-align: justify">Preliminary Proxy Statement</TD>
</TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#9744;</FONT></TD><TD>Confidential, for Use of the Commission Only (as permitted by Rule&nbsp;14a-6(e)(2))</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#9746;</FONT></TD><TD>Definitive Proxy Statement</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#9744;</FONT></TD><TD>Definitive Additional Materials</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#9744;</FONT></TD><TD>Soliciting Material Under Rule&nbsp;14a-12</TD></TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">LANTERN
PHARMA INC.<BR>
(Name of Registrant as Specified In Its Charter)</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"></P>

<!-- Field: Rule-Page --><DIV STYLE="margin-left: auto; margin-right: auto; width: 50%"><DIV STYLE="font-size: 1pt; border-top: Black 1.5pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">(Name
of Person(s) Filing Proxy Statement, if other than the Registrant)</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Payment
of Filing Fee (Check the appropriate box):</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#9746;</FONT></TD><TD>No fee required.</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#9744;</FONT></TD><TD>Fee paid previously with preliminary materials</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#9744;</FONT></TD><TD>Fee computed on table in exhibit required by Item 25(b) per Exchange Act Rules 14a-6(i)(1) and 0-11.</TD></TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Rule-Page --><DIV STYLE="margin-top: 0; margin-bottom: 0; width: 100%"><DIV STYLE="font-size: 1pt; border-top: Black 1pt solid; border-bottom: Black 2pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">April
26, 2022</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Dear
Stockholder:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">You
are cordially invited to attend the 2022 Annual Meeting of Stockholders (which we refer to as the &ldquo;Annual Meeting&rdquo;) of Lantern
Pharma Inc., a Delaware corporation (which we refer to as &ldquo;Lantern,&rdquo; &ldquo;we,&rdquo; &ldquo;us,&rdquo; &ldquo;our,&rdquo;
or the &ldquo;Company&rdquo;), to be held at 11:00 a.m. Eastern time, on Wednesday, June 8, 2022.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">This
year&rsquo;s Annual Meeting will be conducted via live audio webcast and online stockholder tools. Stockholders will be able to attend
and listen to the Annual Meeting live, submit questions and vote their shares electronically at the Annual Meeting from virtually any
location around the world.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">At the Annual Meeting, you will
be asked to consider and vote upon the following proposals to: (1) elect six (6) directors to serve for the ensuing year as members of
the Board of Directors of the Company; (2) ratify the appointment of EisnerAmper LLP as our independent registered public accounting firm
for the fiscal year ending December 31, 2022; and (3) approve an adjournment of the Annual Meeting, if necessary, to solicit additional
proxies if there are not sufficient votes in favor of the foregoing proposals. The accompanying Proxy Statement describes these matters
in more detail. We urge you to read this information carefully.</P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">The
Board of Directors recommends a vote: FOR each of the six (6) nominees for director named in the Proxy Statement; FOR the ratification
of the appointment of EisnerAmper LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2022;
and FOR an adjournment of the Annual Meeting, if necessary, to solicit additional proxies if there are not sufficient votes in favor
of the foregoing proposals.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">Whether
or not you plan to attend the Annual Meeting in person, and regardless of the number of shares of Lantern that you own, it is important
that your shares be represented and voted at the Annual Meeting. Therefore, I urge you to vote your shares of common stock via the Internet
or by promptly marking, dating, signing, and returning a proxy card via mail. Voting over the Internet, or by written proxy, will ensure
that your shares are represented at the Annual Meeting.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">On
behalf of the Board of Directors of Lantern, we thank you for your participation.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 60%">&nbsp;</TD>
    <TD STYLE="width: 40%"><FONT STYLE="font-size: 10pt">Sincerely,</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid"><FONT STYLE="font-size: 10pt">/s/ Donald J. Keyser</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-size: 10pt">Donald J. Keyser,</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-size: 10pt"><I>Chairman of the Board of Directors</I></FONT></TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">LANTERN
PHARMA INC.<BR>
1920 McKinney Avenue, 7<SUP>th</SUP> Floor<BR>
Dallas, Texas 75201</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">NOTICE
OF 2022 ANNUAL MEETING OF STOCKHOLDERS<BR>
TO BE HELD ON JUNE 8, 2022</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">The
2022 Annual Meeting of Stockholders (which we refer to as the &ldquo;Annual Meeting&rdquo;) of Lantern Pharma Inc., a Delaware corporation
(which we refer to as &ldquo;Lantern,&rdquo; &ldquo;we,&rdquo; &ldquo;us,&rdquo; &ldquo;our,&rdquo; or the &ldquo;Company&rdquo;), will
be held on Wednesday, June 8, 2022 at 11:00 a.m. Eastern time. This year&rsquo;s meeting is a virtual stockholder meeting conducted exclusively
via a live audio webcast at <I>www.virtualshareholdermeeting.com/LTRN2022</I>. Stockholders will be able to attend and listen to the
Annual Meeting live, submit questions and vote their shares electronically at the Annual Meeting from virtually any location around the
world. In order to attend and vote at the Annual Meeting, please follow the instructions in the section titled &ldquo;Voting at the Meeting&rdquo;
on page 3. We will consider and act on the following items of business at the Annual Meeting:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">1.</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">To
                                            elect six (6) directors to serve as members of the Board of Directors of the Company (which
                                            we refer to as our &ldquo;Board&rdquo;) until the next annual meeting of stockholders and
                                            until their successors are duly elected and qualified. The director nominees named in the
                                            Proxy Statement for election to our Board are: Donald Jeff Keyser, Panna Sharma, Vijay Chandru,
                                            Maria Maccecchini, Franklyn Prendergast, and David S. Silberstein;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">2.</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">To
                                            ratify the appointment of EisnerAmper LLP as the Company&rsquo;s independent registered public
                                            accounting firm for the year ending December 31, 2022; and</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">3.</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">To
                                            approve an adjournment of the Annual Meeting, if necessary, to solicit additional proxies
                                            if there are not sufficient votes in favor of the foregoing proposals.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">We
intend to mail the Proxy Materials on or about May 2, 2022 to all stockholders of record entitled to vote at the Annual Meeting.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">The
accompanying Proxy Statement describes each of these items of business in detail. Only stockholders of record at the close of business
on April 19, 2022 are entitled to receive notice of, attend and vote at the Annual Meeting or any continuation, postponement or adjournment
thereof.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">All
stockholders are cordially invited to attend the Annual Meeting via the Internet at <I>www.virtualshareholdermeeting.com/LTRN2022</I>.
To ensure your representation at the Annual Meeting, you are urged to vote your shares of common stock via the Internet or by promptly
marking, dating, signing, and returning the proxy card via mail. Voting instructions are provided on the proxy card and included in the
accompanying Proxy Statement. Any stockholder attending the Annual Meeting may vote at the meeting even if he or she previously submitted
a proxy. If your shares of common stock are held by a bank, broker or other agent, please follow the instructions from your bank, broker
or other agent to have your shares voted.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-bottom: 1.5pt; width: 60%">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; width: 40%"><FONT STYLE="font-size: 10pt">/s/ Donald J. Keyser</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-size: 10pt">Donald J. Keyser,</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-size: 10pt"><I>Chairman of the Board of Directors</I></FONT></TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">Dallas, Texas<BR>
April 26, 2022</FONT></P>


<!-- Field: Page; Sequence: 3 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">TABLE
OF CONTENTS</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>



<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 90%; text-align: right">&nbsp;</TD>
    <TD STYLE="width: 10%; text-align: center"><FONT STYLE="font-size: 10pt"><B>Page</B></FONT></TD></TR>
  <TR>
    <TD STYLE="vertical-align: top; text-align: right">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; text-align: right">&nbsp;</TD></TR>
  <TR STYLE="background-color: rgb(204,238,255)">
    <TD STYLE="vertical-align: top"><FONT STYLE="font-size: 10pt"><A HREF="#a_001">INFORMATION ABOUT THE ANNUAL MEETING</A></FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: right"><FONT STYLE="font-size: 10pt">1</FONT></TD></TR>
  <TR STYLE="background-color: White">
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; text-align: right">&nbsp;</TD></TR>
  <TR STYLE="background-color: rgb(204,238,255)">
    <TD STYLE="vertical-align: top"><FONT STYLE="font-size: 10pt"><A HREF="#a_002">PROPOSAL NO. 1 ELECTION OF DIRECTORS</A></FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: right"><FONT STYLE="font-size: 10pt">6</FONT></TD></TR>
  <TR STYLE="background-color: White">
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; text-align: right">&nbsp;</TD></TR>
  <TR STYLE="background-color: rgb(204,238,255)">
    <TD STYLE="vertical-align: top"><FONT STYLE="font-size: 10pt"><A HREF="#a_003">OUR BOARD RECOMMENDS A VOTE &ldquo;FOR&rdquo; EACH OF THE SIX (6) NOMINEES FOR DIRECTOR NAMED IN THIS PROXY STATEMENT.</A></FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: right"><FONT STYLE="font-size: 10pt">6</FONT></TD></TR>
  <TR STYLE="background-color: White">
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; text-align: right">&nbsp;</TD></TR>
  <TR STYLE="background-color: rgb(204,238,255)">
    <TD STYLE="vertical-align: top"><FONT STYLE="font-size: 10pt"><A HREF="#a_004">CORPORATE GOVERNANCE</A></FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: right"><FONT STYLE="font-size: 10pt">9</FONT></TD></TR>
  <TR STYLE="background-color: White">
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; text-align: right">&nbsp;</TD></TR>
  <TR STYLE="background-color: rgb(204,238,255)">
    <TD STYLE="vertical-align: top"><FONT STYLE="font-size: 10pt"><A HREF="#a_006">PROPOSAL NO. 2 RATIFICATION OF APPOINTMENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM</A></FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: right"><FONT STYLE="font-size: 10pt">13</FONT></TD></TR>
  <TR STYLE="background-color: White">
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; text-align: right">&nbsp;</TD></TR>
  <TR STYLE="background-color: rgb(204,238,255)">
    <TD STYLE="vertical-align: top"><FONT STYLE="font-size: 10pt"><A HREF="#a_005">PROPOSAL NO. 3 APPROVE AN ADJOURNMENT OF THE ANNUAL MEETING, IF NECESSARY, TO SOLICIT ADDITIONAL PROXIES IF THERE ARE NOT SUFFICIENT VOTES IN FAVOR OF PROPOSALS 1 OR 2</A></FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: right"><FONT STYLE="font-size: 10pt">15</FONT></TD></TR>
  <TR STYLE="background-color: White">
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; text-align: right">&nbsp;</TD></TR>
  <TR STYLE="background-color: rgb(204,238,255)">
    <TD STYLE="vertical-align: top"><FONT STYLE="font-size: 10pt"><A HREF="#a_007">SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT AND RELATED STOCKHOLDER MATTERS</A></FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: right"><FONT STYLE="font-size: 10pt">16</FONT></TD></TR>
  <TR STYLE="background-color: White">
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; text-align: right">&nbsp;</TD></TR>
  <TR STYLE="background-color: rgb(204,238,255)">
    <TD STYLE="vertical-align: top"><FONT STYLE="font-size: 10pt"><A HREF="#a_008">EXECUTIVE OFFICERS AND COMPENSATION</A></FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: right"><FONT STYLE="font-size: 10pt">18</FONT></TD></TR>
  <TR STYLE="background-color: White">
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; text-align: right">&nbsp;</TD></TR>
  <TR STYLE="background-color: rgb(204,238,255)">
    <TD STYLE="vertical-align: top"><FONT STYLE="font-size: 10pt"><A HREF="#a_009">CERTAIN RELATIONSHIPS AND RELATED PARTY TRANSACTIONS</A></FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: right"><FONT STYLE="font-size: 10pt">23</FONT></TD></TR>
  <TR STYLE="background-color: White">
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; text-align: right">&nbsp;</TD></TR>
  <TR STYLE="background-color: rgb(204,238,255)">
    <TD STYLE="vertical-align: top"><FONT STYLE="font-size: 10pt"><A HREF="#a_010">OTHER MATTERS</A></FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: right"><FONT STYLE="font-size: 10pt">24</FONT></TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 4; Options: NewSection; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: LowerRoman; Name: PageNo -->i<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->


<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">LANTERN
PHARMA INC.<BR>
1920 McKinney Avenue, 7<SUP>th</SUP> Floor<BR>
Dallas, Texas 75201</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">PROXY
STATEMENT<BR>
FOR ANNUAL MEETING OF STOCKHOLDERS<BR>
TO BE HELD ON JUNE 8, 2022</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif"><A NAME="a_001"></A>INFORMATION
ABOUT THE ANNUAL MEETING</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">General</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">Your
proxy is solicited on behalf of the Board of Directors (which we refer to as our &ldquo;Board&rdquo;) of Lantern Pharma Inc., a Delaware
corporation (which we refer to as &ldquo;Lantern,&rdquo; &ldquo;we,&rdquo; &ldquo;us,&rdquo; &ldquo;our,&rdquo; or the &ldquo;Company&rdquo;),
for use at our 2022 Annual Meeting of Stockholders (which we refer to as the &ldquo;Annual Meeting&rdquo;). This year&rsquo;s meeting
is a virtual stockholder meeting conducted exclusively via a live audio webcast at <I>www.virtualshareholdermeeting.com/LTRN2022</I>.
The Annual Meeting will be held on Wednesday, June 8, 2022, at 11:00 a.m. Eastern time, or at any continuation, postponement or adjournment
thereof, for the purposes discussed in this Proxy Statement. Proxies are solicited to give all stockholders of record an opportunity
to vote on matters properly presented at the Annual Meeting.</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">Important
Notice Regarding the Availability of Proxy Materials for the Stockholders&rsquo;<BR>
Meeting to Be Held Via the Internet at <I>www.virtualshareholdermeeting.com/LTRN2022</I></FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">on
Wednesday, June 8, 2022 at 11:00 a.m. Eastern time</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">The
Annual Report, Notice of Meeting, Proxy Statement and Proxy Card<BR>
are available at <I>www.proxyvote.com</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">We
intend to mail this Proxy Statement, the proxy card and the Notice of Annual Meeting on or about May 2, 2022 to all stockholders of record
entitled to vote at the Annual Meeting. If you would like a hard copy of the proxy materials for this Annual Meeting, or any future stockholder
meetings, mailed or emailed to you, please contact us at the above address or at our webpage <I>http://ir.lanternpharma.com/</I>, or
telephone us at 628-777-3153 or email us at ir@lanternpharma.com. For directions on how to attend the Annual Meeting, please telephone
us at 628-777-3153.</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">How
to Attend</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">You
are entitled to attend and participate in the Annual Meeting if you were a stockholder as of the close of business on April 19, 2022,
the record date, or hold a valid proxy for the meeting. To attend the Annual Meeting, you must access the meeting website at <I>www.virtualshareholdermeeting.com/LTRN2022
</I>and enter the control number set forth on your proxy card. In order to participate in the virtual meeting, including to vote, ask
questions and to view the list of registered stockholders as of the record date during the meeting, you must access the meeting website
at <I>www.virtualshareholdermeeting.com/LTRN2022</I> and enter the control number that may be found on your proxy card. The meeting webcast
will begin promptly at 11:00 a.m. Eastern Time. Online check-in will begin approximately 15 minutes before then and we encourage you
to allow ample time for check-in procedures.</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">Who
Can Vote, Outstanding Shares</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">Record
holders of our common stock as of the close of business on April 19, 2022, the record date for the Annual Meeting, are entitled to vote
at the Annual Meeting on all matters to be voted upon. As of the record date, there were 10,830,947 shares of our common stock outstanding,
each entitled to one vote.</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 5; Options: NewSection; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">Voting
of Shares</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">You
may vote by attending the Annual Meeting and voting at the meeting or you may vote prior to the Annual Meeting through the Internet or
by submitting a proxy. The method of voting by proxy differs for shares held as a record holder and shares held in &ldquo;street name.&rdquo;
If you hold your shares of common stock as a record holder, you may vote your shares over the Internet or by completing, dating and signing
the proxy card and promptly returning the proxy card via mail. If you hold your shares of common stock in street name, which means that
your shares are held of record by a broker, bank or other nominee, you will receive a notice from your broker, bank or other nominee
that includes instructions on how to vote your shares.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">You
may vote your shares as follows:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#9679;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">To
                                            vote in person, attend the Annual Meeting and follow the procedures set forth in &ldquo;Voting
                                            at the Meeting&rdquo;, below.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#9679;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">To
                                            vote through the Internet prior to the Annual Meeting, go to www.proxyvote.com and complete
                                            an electronic proxy card. You will be asked to provide the control number from the proxy
                                            card or, if you hold your shares in street name, the voting instruction form delivered to
                                            you by your broker. Your Internet vote must be received by 11:59 p.m., Eastern Time on June
                                            7, 2022 to be counted.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#9679;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">To
                                            vote prior to the Annual Meeting using the proxy card delivered to you, simply complete,
                                            sign, and date the proxy card and return it promptly in the envelope provided. If you return
                                            your signed proxy card to us before the Annual Meeting, we will vote your shares as you direct.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#9679;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">To
                                            vote prior to the Annual Meeting using any touch-tone telephone, dial 1-800-690-6903. Have
                                            your proxy card or voting instruction form in hand and follow the instructions.</FONT></TD></TR></TABLE>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">YOUR
VOTE IS VERY IMPORTANT.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">You
should submit your proxy even if you plan to attend the Annual Meeting. If you properly give your proxy and submit it to us in time to
vote, one of the individuals named as your proxy will vote your shares as you have directed. Any stockholder attending the Annual Meeting
may vote in person even if he or she previously submitted a proxy.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">All
shares entitled to vote and represented by properly submitted proxies (including those submitted electronically and in writing) received
before the polls are closed at the Annual Meeting, and not revoked or superseded, will be voted at the Annual Meeting in accordance with
the instructions indicated on those proxies. If no direction is indicated on a proxy, your shares will be voted as follows:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#9679;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>FOR
                                            </B>each of the six (6)&nbsp;nominees for director named in the Proxy Statement;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#9679;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>FOR
                                            </B>the ratification of the appointment of EisnerAmper LLP as our independent registered
                                            public accounting firm for the fiscal year ending December 31, 2022; and</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#9679;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>FOR
                                            </B>an adjournment of the Annual Meeting, if necessary, to solicit additional proxies if
                                            there are not sufficient votes in favor of the foregoing proposals.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">With
respect to any other matter that properly comes before the Annual Meeting or any continuation, postponement or adjournment thereof, the
proxy-holders will vote as recommended by our Board, or if no recommendation is given, in their own discretion.</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif"></FONT></P>

<!-- Field: Page; Sequence: 6; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">Revocation
of Proxy</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">If
you are a stockholder of record, you may revoke your proxy at any time before your proxy is voted at the Annual Meeting by taking any
of the following actions:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#9679;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">delivering
                                            to our corporate secretary a signed written notice of revocation, bearing a date later than
                                            the date of the proxy, stating that the proxy is revoked;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#9679;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">signing
                                            and delivering a new proxy card, relating to the same shares and bearing a later date than
                                            the original proxy card;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#9679;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">submitting
                                            another proxy over the Internet (your latest Internet voting instructions are followed);
                                            or</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#9679;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">attending
                                            the Annual Meeting and voting in person, although attendance at the Annual Meeting will not,
                                            by itself, revoke a proxy.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">Written
notices of revocation and other communications with respect to the revocation of Company proxies should be addressed to:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">Lantern
Pharma Inc.<BR>
1920 McKinney Avenue, 7<SUP>th</SUP> Floor<BR>
Dallas, Texas 75201<BR>
Attention: Corporate Secretary</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">If
your shares are held in &ldquo;street name,&rdquo; you may change your vote by submitting new voting instructions to your broker, bank
or other nominee. You must contact your broker, bank or other nominee to find out how to do so. See below regarding how to vote in person
if your shares are held in street name.</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">Voting
at the Meeting</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">If you are a stockholder of
record or hold your shares of common stock in street name, you can vote at the virtual Annual Meeting by accessing the meeting website
at <I>www.virtualshareholdermeeting.com/LTRN2022</I>, entering the control number found on your proxy card or, if you hold your shares
of common stock in street name, entering the control number on the voting instruction form delivered to you by your broker and following
the instructions on the website for voting at the Annual Meeting.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">Additional
information regarding the rules and procedures for participating in the Annual Meeting will be set forth in our meeting rules of conduct,
which stockholders can view during the meeting at the meeting website. We will also post a recording of the meeting on our investor relations
website, which will be available for replay following the meeting for 60 days.</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">Quorum
and Votes Required</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">The
inspector of election appointed for the Annual Meeting will tabulate votes cast by proxy or in person at the Annual Meeting. The inspector
of election will also determine whether a quorum is present. In order to constitute a quorum for the conduct of business at the Annual
Meeting, not less than a majority of the voting power of all of the shares of the stock entitled to vote at the Annual Meeting must be
present in person or represented by proxy at the Annual Meeting. Shares that abstain from voting on any proposal, or that are represented
by broker non-votes (as discussed below), will be treated as shares that are present and entitled to vote at the Annual Meeting for purposes
of determining whether a quorum is present. If there is no quorum, the holders of a majority of the shares present at the Annual Meeting
in person or represented by proxy may adjourn the Annual Meeting to another date.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 7; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">A
broker non-vote occurs when a broker, bank or other agent holding shares for a beneficial owner has not received instructions from the
beneficial owner and does not have discretionary authority to vote the shares for certain non-routine matters. Shares represented by
proxies that reflect a broker non-vote will be counted for purposes of determining the presence of a quorum. We believe that the election
of directors (Proposal 1) will be considered a non-routine matter and broker non-votes, if any, will not be counted as votes cast and
will have no effect on the result of the vote. We believe that the ratification of the appointment of EisnerAmper LLP as our independent
registered public accounting firm (Proposal 2) will be considered a routine matter on which a broker, bank or other agent will have discretionary
authority to vote, and on this basis we do not expect any broker non-votes in connection with this proposal.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B><U>Proposal
No. 1</U>: <I>Election of Directors</I></B>. A plurality of the votes cast by the holders of shares entitled to vote in the election
of directors at the Annual Meeting is required for the election of directors. Accordingly, the six (6) director nominees receiving the
highest number of votes will be elected. Abstentions and broker non-votes are not treated as votes cast and, therefore, will not have
any effect on the outcome of the election of directors.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B><U>Proposal
No. 2</U>: <I>Ratification of Independent Registered Public Accounting Firm</I></B>. The affirmative vote of the holders of a majority
of the votes present and entitled to vote at the Annual Meeting is required for the ratification of the appointment of EisnerAmper LLP
as our independent registered public accounting firm for the fiscal year ending December 31, 2022. We believe that brokers will have
discretionary authority to vote on the ratification of our independent registered public accounting firm and, therefore, we do not expect
there to be broker non-votes resulting from the vote on Proposal No. 2. However, in the event of any broker non-votes or abstentions
in connection with Proposal No. 2, such broker non-votes and abstentions will have the effect of a vote against this proposal.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B><U>Proposal
No. 3</U>: <I>Approval to Adjourn the Annual Meeting</I></B>. The affirmative vote of the holders of a majority of the votes present
and entitled to vote at the Annual Meeting is required for the approval of an adjournment of the Annual Meeting, if necessary, to solicit
additional proxies if there are not sufficient votes in favor of Proposals 1 or 2. We believe that brokers will have discretionary authority
to vote on an adjournment of the Annual Meeting, if necessary, to solicit additional proxies and, therefore, we do not expect there to
be broker non-votes resulting from the vote on Proposal No. 3. However, in the event of any broker non-votes or abstentions in connection
with Proposal No. 3, such broker non-votes and abstentions will have the effect of a vote against this proposal.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">We
will also consider any other business that properly comes before the Annual Meeting, or any adjournment or postponement thereof. As of
the record date, we are not aware of any other matters to be submitted for consideration at the Annual Meeting. If any other matters
are properly brought before the Annual Meeting, the persons designated as proxies will vote the shares as recommended by our Board, or
if no recommendation is given, in their own discretion.</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">Solicitation
of Proxies</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">Our
Board is soliciting proxies for the Annual Meeting from our stockholders. We will bear the entire cost of soliciting proxies from our
stockholders. In addition to the solicitation of proxies by delivery of this Proxy Statement by mail, we will request that brokers, banks
and other nominees that hold shares of our common stock, which are beneficially owned by our stockholders, forward proxy materials to
those beneficial owners and secure those beneficial owners&rsquo; voting instructions. We will reimburse those record holders for their
reasonable expenses. We do not intend to hire a proxy solicitor to assist in the solicitation of proxies. We may use several of our regular
employees, who will not be specially compensated, to solicit proxies from our stockholders, either personally or by Internet, facsimile
or special delivery letter.</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif"></FONT></P>

<!-- Field: Page; Sequence: 8; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">Stockholder
List</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">A
list of stockholders eligible to vote at the Annual Meeting will be available for inspection, for any purpose germane to the Annual Meeting,
during the Annual Meeting at the meeting website and at the principal executive office of the Company during regular business hours for
a period of no less than ten (10) days prior to the Annual Meeting.</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">Forward-Looking
Statements</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">This Proxy Statement contains
&ldquo;forward-looking statements&rdquo; (as defined in the Private Securities Litigation Reform Act of 1995). These statements are based
on our current expectations and involve risks and uncertainties, which may cause results to differ materially from those set forth in
the statements. The forward-looking statements may include statements regarding actions to be taken by us. We undertake no obligation
to publicly update any forward-looking statement, whether as a result of new information, future events or otherwise. Forward-looking
statements should be evaluated together with the many uncertainties that affect our business, particularly those mentioned in the risk
factors in Item 1A of our Annual Report on Form 10-K <FONT STYLE="background-color: white">for the year ended December 31, 2021, filed
with the Securities and Exchange Commission on March 10, 2022</FONT> (the &ldquo;2021 Annual Report&rdquo;) and in our Quarterly Reports
on Form 10-Q and our Current Reports on Form 8-K.</P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif"></FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 9; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif"><A NAME="a_002"></A>PROPOSAL
NO. 1<BR>
ELECTION OF DIRECTORS</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">Board
Nominees</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">Our
Board currently consists of six (6) members, five (5) of whom are independent under the listing standards for independence of the NASDAQ
and Rule 10A-3 under the Securities Exchange Act of 1934, as amended (which we refer to as the &ldquo;Exchange Act&rdquo;). However,
one of our current directors, Leslie W. Kreis, Jr., has elected not to stand for reelection. Based upon the recommendation of the Nominating
and Corporate Governance Committee of our Board, our Board determined to nominate the other five (5) current members of the Board and
director nominee, Maria Maccecchini, for election at the Annual Meeting.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">Our
Board and the Nominating and Corporate Governance Committee believe the following director nominees collectively have the experience,
qualifications, attributes and skills to effectively oversee the management of the Company, including a high degree of personal and professional
integrity, an ability to exercise sound business judgment on a broad range of issues, sufficient experience and background to have an
appreciation of the issues facing the Company, a willingness to devote the necessary time to Board duties, a commitment to representing
the best interests of the Company and our stockholders and a dedication to enhancing stockholder value.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">Each
director elected at the Annual Meeting will serve a one (1) year term until the Company&rsquo;s next annual meeting and until his or
her successor is duly elected and qualified or until his or her earlier death, resignation or removal. Unless otherwise instructed, the
proxy-holders will vote the proxies received by them for the six (6) nominees named below. If any of the nominees is unable or declines
to serve as a director at the time of the Annual Meeting, the proxies will be voted for any nominee designated by the present Board to
fill the vacancy. It is not presently expected that any of the nominees named below will be unable or will decline to serve as a director.
If additional persons are nominated for election as directors, the proxy-holders intend to vote all proxies received by them in a manner
to assure the election of as many of the nominees listed below as possible. In such event, the specific nominees to be voted for will
be determined by the proxy-holders.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">Set
forth below are the names, ages and positions of our director nominees as of the date of this Proxy Statement:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="border-bottom: Black 1.5pt solid; width: 32%"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Name</B></FONT></P></TD>
    <TD STYLE="font: normal 10pt Times New Roman, Times, Serif; white-space: nowrap; width: 2%; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></TD>
    <TD STYLE="font: normal 10pt Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; width: 7%; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Age</B></FONT></TD>
    <TD STYLE="font: normal 10pt Times New Roman, Times, Serif; white-space: nowrap; width: 2%; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></TD>
    <TD STYLE="font: normal 10pt Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; width: 57%; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Position</B></FONT></TD></TR>
  <TR STYLE="font: normal 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF">
    <TD STYLE="font: normal 10pt Times New Roman, Times, Serif; padding-bottom: 2.25pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">Donald
    Jeff Keyser<SUP>(a),(b)</SUP></FONT></TD>
    <TD STYLE="font: normal 10pt Times New Roman, Times, Serif; white-space: nowrap; padding-bottom: 2.25pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">&nbsp;</FONT></TD>
    <TD STYLE="font: normal 10pt Times New Roman, Times, Serif; padding-bottom: 2.25pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">69</FONT></TD>
    <TD STYLE="font: normal 10pt Times New Roman, Times, Serif; white-space: nowrap; padding-bottom: 2.25pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">&nbsp;</FONT></TD>
    <TD STYLE="font: normal 10pt Times New Roman, Times, Serif; padding-bottom: 2.25pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">Chairman
    of the Board</FONT></TD></TR>
  <TR STYLE="font: normal 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <TD STYLE="font: normal 10pt Times New Roman, Times, Serif; padding-bottom: 2.25pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">Panna
    Sharma</FONT></TD>
    <TD STYLE="font: normal 10pt Times New Roman, Times, Serif; white-space: nowrap; padding-bottom: 2.25pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">&nbsp;</FONT></TD>
    <TD STYLE="font: normal 10pt Times New Roman, Times, Serif; padding-bottom: 2.25pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">51</FONT></TD>
    <TD STYLE="font: normal 10pt Times New Roman, Times, Serif; white-space: nowrap; padding-bottom: 2.25pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">&nbsp;</FONT></TD>
    <TD STYLE="font: normal 10pt Times New Roman, Times, Serif; padding-bottom: 2.25pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">Chief
    Executive Officer, President and Director</FONT></TD></TR>
  <TR STYLE="font: normal 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF">
    <TD STYLE="font: normal 10pt Times New Roman, Times, Serif; padding-bottom: 2.25pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">Vijay
    Chandru<SUP>(a),(c)</SUP></FONT></TD>
    <TD STYLE="font: normal 10pt Times New Roman, Times, Serif; white-space: nowrap; padding-bottom: 2.25pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">&nbsp;</FONT></TD>
    <TD STYLE="font: normal 10pt Times New Roman, Times, Serif; padding-bottom: 2.25pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">68</FONT></TD>
    <TD STYLE="font: normal 10pt Times New Roman, Times, Serif; white-space: nowrap; padding-bottom: 2.25pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">&nbsp;</FONT></TD>
    <TD STYLE="font: normal 10pt Times New Roman, Times, Serif; padding-bottom: 2.25pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">Director</FONT></TD></TR>
  <TR STYLE="font: normal 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <TD STYLE="font: normal 10pt Times New Roman, Times, Serif; padding-bottom: 2.25pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">Maria
    Maccecchini</FONT></TD>
    <TD STYLE="font: normal 10pt Times New Roman, Times, Serif; white-space: nowrap; padding-bottom: 2.25pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">&nbsp;</FONT></TD>
    <TD STYLE="font: normal 10pt Times New Roman, Times, Serif; padding-bottom: 2.25pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">71</FONT></TD>
    <TD STYLE="font: normal 10pt Times New Roman, Times, Serif; white-space: nowrap; padding-bottom: 2.25pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">&nbsp;</FONT></TD>
    <TD STYLE="font: normal 10pt Times New Roman, Times, Serif; padding-bottom: 2.25pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">Director
    Nominee</FONT></TD></TR>
  <TR STYLE="font: normal 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF">
    <TD STYLE="font: normal 10pt Times New Roman, Times, Serif; padding-bottom: 2.25pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">Franklyn
    Prendergast<SUP>(a),(c)</SUP></FONT></TD>
    <TD STYLE="font: normal 10pt Times New Roman, Times, Serif; white-space: nowrap; padding-bottom: 2.25pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">&nbsp;</FONT></TD>
    <TD STYLE="font: normal 10pt Times New Roman, Times, Serif; padding-bottom: 2.25pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">77</FONT></TD>
    <TD STYLE="font: normal 10pt Times New Roman, Times, Serif; white-space: nowrap; padding-bottom: 2.25pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">&nbsp;</FONT></TD>
    <TD STYLE="font: normal 10pt Times New Roman, Times, Serif; padding-bottom: 2.25pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">Director</FONT></TD></TR>
  <TR STYLE="font: normal 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <TD STYLE="font: normal 10pt Times New Roman, Times, Serif; padding-bottom: 2.25pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">David
    S. Silberstein</FONT></TD>
    <TD STYLE="font: normal 10pt Times New Roman, Times, Serif; white-space: nowrap; padding-bottom: 2.25pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">&nbsp;</FONT></TD>
    <TD STYLE="font: normal 10pt Times New Roman, Times, Serif; padding-bottom: 2.25pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">71</FONT></TD>
    <TD STYLE="font: normal 10pt Times New Roman, Times, Serif; white-space: nowrap; padding-bottom: 2.25pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">&nbsp;</FONT></TD>
    <TD STYLE="font: normal 10pt Times New Roman, Times, Serif; padding-bottom: 2.25pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-weight: normal">Director</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Rule-Page --><DIV STYLE="width: 25%"><DIV STYLE="font-size: 1pt; border-top: Black 1.5pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">(a)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Member
of the Audit Committee of our Board.</FONT></TD>
</TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">(b)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Member
of the Compensation Committee of our Board.</FONT></TD>
</TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">(c)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Member
of the Nominating and Corporate Governance Committee of our Board.</FONT></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">Board
Recommendation</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif"><A NAME="a_003"></A>OUR
BOARD RECOMMENDS A VOTE &ldquo;FOR&rdquo; EACH OF THE SIX (6) NOMINEES FOR DIRECTOR NAMED IN THIS PROXY STATEMENT.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">Vacancies
on our Board, including any vacancy created by an increase in the size of our Board, may be filled by a majority of the directors remaining
in office (even though less than a quorum of our Board) or a sole remaining director. A director elected by our Board to fill a vacancy
will serve until the next annual meeting of stockholders and until such director&rsquo;s successor is elected and qualified, or until
such director&rsquo;s earlier retirement, resignation, disqualification, removal or death.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 10; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">If
any nominee should become unavailable for election prior to the Annual Meeting, an event that currently is not anticipated by our Board,
the proxies will be voted in favor of the election of a substitute nominee or nominees proposed by our Board. Each nominee has agreed
to serve if elected and our Board has no reason to believe that any nominee will be unable to serve.</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">Information
about Director Nominees</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">Set
forth below is biographical information for each nominee and a summary of the specific qualifications, attributes, skills and experiences
which led our Board to conclude that each nominee should serve on our Board at this time. There are no family relationships among any
of the directors, director nominees or executive officers of the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif"><I>&nbsp;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif"><I>Donald
Jeff Keyser</I> has served as a director since January 2018 and Chairman since November 2019. Dr. Keyser founded and has served from
2017 as director, president and chief operating officer of Renibus Therapeutics, a company developing novel therapies for the diagnosis,
treatment and prevention of kidney disease. Dr. Keyser also founded ZS Pharma and served since 2008 as a director and chief operating
officer of that company until December 2015 when it was acquired by Astra Zeneca for $2.7 Billion. Dr. Keyser was the inventor of the
Mucinex product line for Adams Respiratory Therapeutics. Dr. Keyser developed and executed the R&amp;D and Regulatory strategy for Adams
Respiratory Therapeutics as Vice President of Development and Regulatory Affairs during his period there from 1998 to 2004. Adams Respiratory
Therapeutics was acquired by Reckitt Benckiser for $2.3 Billion. He was previously employed as Chief Compliance Officer &amp; Vice President
Regulatory Affairs, Encysive Pharmaceuticals, Vice President Technical &amp; Regulatory Affairs, Medeva Americas, Sr. Director Regulatory
Affairs, Marion Merrell Dow and Regulatory Principal, Abbott Laboratories. Dr. Keyser received his Pharmacy degree from Creighton University,
a Juris Doctorate from Creighton University, a MPA from the University of Missouri-Kansas City and a PhD in Economics from The University
of Texas at Dallas. Based on the above qualifications, the Company believes Dr. Keyser is qualified to be on the Board.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif"><I>&nbsp;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif"><I>Panna
Sharma</I> has served as our Chief Executive Officer and President since July 2018 and a director since August 2018. As Chief Executive
Officer, Mr. Sharma oversees our use of AI and genomics in developing our therapy product pipeline to innovate the rescue, revitalization
and development of precision therapeutics in oncology. From May 2010 to February 2018, Mr. Sharma served as President, Chief Executive
Officer and director of Cancer Genetics, a Nasdaq company and provider of DNA-based cancer diagnostics and services to medical institutions
throughout the world. In 2001, Mr. Sharma founded TSG Partners, a specialty advisory group combining corporate strategy and corporate
finance to create stockholder value for companies and investors in the life sciences, biotechnology and environmental sciences sectors.
Prior to TSG, Mr. Sharma served in the roles of Senior Vice President of E-Business Solutions and Chief Strategy Officer at iXL Inc.
(later merged with Scient). For the six years prior to his being at iXL Inc., Mr. Sharma helped successfully found, manage and sell or
take public two other consulting and professional services firms. From 1996 to 1998, Mr. Sharma was a partner at Interactive Solutions,
Inc. Prior to that, Mr. Sharma served as a consultant to Putnam Investment Management, LLC and Bank of America Corporation. Mr. Sharma
holds a Bachelor of Science in the Philosophy of Science, Neural Networks and Artificial Intelligence from Boston University. Based on
the above qualifications, the Company believes Mr. Sharma is qualified to be on the Board.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif"><I>&nbsp;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif"><I>Vijay
Chandru</I> has served as a director since October 2019. Currently, Dr. Chandru is a co-founder of OPFORD Foundation, a non-profit in
India with an open platform for orphan diseases and with a mission to support development of affordable and accessible therapeutics for
orphan diseases of which many are rare genetic disorders. He was also a co-founder of Strand Life Sciences, India&rsquo;s leading precision
medicine solutions company, an offshoot of the Indian Institute of Science, which now has over 20 diagnostic laboratories and over 800
employees spread across India. He served as Executive Chairman of Strand Life Sciences from 2000 to 2018. A technology pioneer of the
World Economic Forum since 2006, he was elected President (2009-2012) of the Association of Biotech Led Enterprises (ABLE), the apex
trade body that represents the Indian biotech industry. Dr. Chandru is an academic entrepreneur whose academic career has spanned almost
four decades. After his doctoral work at MIT he was a tenured professor at Purdue University for a decade in the 1980s and at the Indian
Institute of Science in Bangalore since then. A fellow of both the academy of science and engineering, he is currently an Indian National
Academy of Engineering&rsquo;s Distinguished Technologist in Bio-Engineering. Based on the above qualifications, the Company believes
Dr. Chandru is qualified to be on the Board.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif"><I>&nbsp;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif"><I></I></FONT></P>

<!-- Field: Page; Sequence: 11; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif"><I>&nbsp;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif"><I>Maria
L. Maccecchini </I>is a nominee for election to our Board of Directors. Dr. Maccecchini founded Annovis Bio, Inc. , a New York Stock
Exchange listed, clinical stage, drug platform company addressing neurodegeneration, such as Alzheimer&rsquo;s disease and Parkinson&rsquo;s
disease. She has served as President and CEO and as a director of Annovis since May 2008. Dr. Maccecchini has over 30 years of experience
in neuroscience and the workings of the brain. She was partner and director of two angel groups, Robin Hood Ventures, from 2002 to 2009,
and MidAtlantic Angel Group, from 2005 to 2009. In 1992, she founded and became chief executive officer of Symphony Pharmaceuticals/Annovis,
a biotech company, which was sold in 2001 to Transgenomic. From 1987 to 1991 she was General Manager of Bachem Bioscience, the US subsidiary
of Bachem AG, Switzerland and Head of Molecular Biology at Mallinckrodt. Dr. Maccecchini conducted post-doctoral research at Caltech
and the Roche Institute of Immunology. She earned a Ph.D. in biochemistry from the Biocenter of Basel with a two-year visiting fellowship
at The Rockefeller University. Dr. Maccecchini serves on several boards of biotechnology companies, organizations that promote entrepreneurship,
international trade, women and charitable organizations. She has been a lecturer at Wharton Business School since 2016. Based on the
above qualifications, the Company believes Dr. Maccecchini is qualified to be on the Board.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif"><I>&nbsp;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif"><I>Franklyn
Prendergast</I> has served as a director since October 2019. Prior to his retirement on December 31, 2014, Dr. Prendergast was the Emeritus
Edmond and Marion Guggenheim Professor of Biochemistry and Molecular Biology and Emeritus Professor of Molecular Pharmacology and Experimental
Therapeutics at Mayo Medical School and the director of the Mayo Clinic Center for Individualized Medicine. From 1994 to 2006, he served
as a director of Mayo Clinic Cancer Center. He also previously held several other teaching positions at the Mayo Medical School from
1975 through 2014. Dr. Prendergast has served for the National Institute of Health on numerous study section review groups; as a charter
member of the Board of Advisors for the Division of Research Grants, now the Center for Scientific Review; the National Advisory General
Medical Sciences Council; and the Board of Scientific Advisors of the National Cancer Institute. He held a Presidential Commission for
service on the National Cancer Advisory Board. Dr. Prendergast also has served in numerous other advisory roles for the National Institute
of Health and the National Research Council of the National Academy of Sciences, and he is a member of the board of directors of the
Translational Genomics Research Institute and the Infectious Disease Research Institute (IDRI). Dr. Prendergast has served on the board
of directors of Eli Lilly &amp; Co. since 1995 until his retirement in 2017. He also served as a director of Cancer Genetics from 2014
to 2018. He also currently serves on the board of directors for Novosteo, Inc. and Neubase Therapeutics, both private biotechnology drug
development companies. Dr. Prendergast obtained his medical degree with honors from the University of West Indies and attended Oxford
University as a Rhodes Scholar, earning an M.A. degree in physiology. He obtained his Ph.D. in Biochemistry at the University of Minnesota.
Based on the above qualifications, the Company believes Dr. Prendergast is qualified to be on the Board.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif"><I>&nbsp;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif"><I>David
S. Silberstein</I> has served as a director since June 2018. Dr. Silberstein has served as chief operating officer of BioMimetix JV,
LLC since 2013. Dr. Silberstein has served as a director of Biological Mimetics, Inc. since 2016. Dr. Silberstein received his PhD in
Immunology at Columbia University and Postdoctoral training at Harvard Medical School/Brigham &amp; Women&rsquo;s Hospital. Dr. Silberstein
continued for seven years at Harvard, leading a research team studying the biochemistry of inflammation. This was followed by 20 years
at AstraZeneca Pharmaceuticals where Dr. Silberstein had leadership roles in genomics, translational science, company-wide portfolio
management, and science support for two products through launch to aggregate sales of greater than $30 billion. Since 2013, Dr. Silberstein
has worked independently with a number of early stage biotech companies and as a consultant to investment firms. Current work includes
his role as Principal Investigator of an NCI-funded clinical trial in patients with multiple brain metastases. Based on the above qualifications,
the Company believes Dr. Silberstein is qualified to be on the Board.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif"></FONT></P>

<!-- Field: Page; Sequence: 12; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif"><A NAME="a_004"></A>CORPORATE
GOVERNANCE</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">Board
Composition</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">Our
Board may establish the authorized number of directors from time to time by resolution. Our Board currently consists of six (6) authorized
members. During the year ended December 31, 2021, our Board met ten (10) times and acted by unanimous written consent six (6) times.
Our Board does not have a policy regarding Board members&rsquo; attendance at meetings of our stockholders, however five members of our
Board attended our 2021 annual meeting of stockholders. During the year ended December 31, 2021, all directors attended at least 75%
of all meetings of the Board and Board committees on which they served, except for Vijay Chandru who attended 65% of such meetings.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">Generally, under the listing requirements
and rules of the Nasdaq Stock Market, independent directors must comprise a majority of a listed company&rsquo;s board of directors. Our
Board has undertaken a review of its composition, the composition of its committees and the independence of each director. Our Board has
determined that, other than Mr. Sharma, none of our director nominees has a relationship that would interfere with the exercise of independent
judgment in carrying out the responsibilities of a director and that each is &ldquo;independent&rdquo; as that term is defined under the
applicable rules and regulations of the SEC and the listing requirements and rules of the Nasdaq Stock Market. In making these determinations,
our Board considered the current and prior relationships that each nonemployee director nominee has with our Company and all other facts
and circumstances our Board deemed relevant in determining their independence, including the beneficial ownership of our capital stock
by each nonemployee director nominee. Accordingly, a majority of our directors are independent, as required under applicable Nasdaq Stock
Market rules, as of the date of this Proxy Statement.</P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">Committees
of the Board of Directors</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">Our
Board has established an Audit Committee, a Compensation Committee and a Nominating and Corporate Governance Committee. Our Board may
establish other committees to facilitate the management of our business. The composition and functions of each committee are described
below. Members serve on these committees until their resignation or until otherwise determined by our Board.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">Each
of our committees operates under a written charter, copies of which are available at our investor relations website located at <I>ir.lanternpharma.com/corporate-governance/governance-documents</I>.</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">Audit
Committee</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">Our
Audit Committee consists of Donald Jeff Keyser, Vijay Chandru and Franklyn Prendergast, with Dr. Keyser serving as chair. The composition
of our Audit Committee meets the requirements for independence under current Nasdaq Stock Market listing standards and SEC rules and
regulations. Each member of our Audit Committee meets the financial literacy requirements of the Nasdaq Stock Market listing standards
and is also a nonemployee director, as defined pursuant to Rule 16b-3 promulgated under the Exchange Act. Dr. Keyser is an audit committee
financial expert within the meaning of Item 407(d) of Regulation S-K under the Securities Act of 1933, as amended, or the Securities
Act. Our Audit Committee, among other things:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#9679;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">selects
                                            a qualified firm to serve as the independent registered public accounting firm to audit our
                                            financial statements;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#9679;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">discusses
                                            the scope and results of the audit with the independent registered public accounting firm;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#9679;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">reviews,
                                            with management and the independent registered public accounting firm, our interim and year-end
                                            operating results;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#9679;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">develops
                                            procedures for employees to submit concerns anonymously about questionable accounting or
                                            audit matters;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in"></P>

<!-- Field: Page; Sequence: 13; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#9679;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">reviews
                                            our policies on risk assessment and risk management;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#9679;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">reviews
                                            related-party transactions; and</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#9679;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">approves
                                            (or, as permitted, pre-approves) all audit and all permissible nonaudit services, other than
                                            de minimis nonaudit services, to be performed by the independent registered public accounting
                                            firm.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">Our
Audit Committee operates under a written charter that satisfies the applicable rules of the SEC and the listing standards of the Nasdaq
Stock Market. During the year ended December 31, 2021, our Audit Committee met five times.</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">Compensation
Committee</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">Our
Compensation Committee currently consists of Leslie W. Kreis, Jr. and Donald Jeff Keyser, with Mr. Kreis serving as Chair. However, as
noted above, Mr. Kreis has elected not to stand for reelection and following the Annual Meeting we intend to reconstitute our Compensation
Committee. The composition of our Compensation Committee meets the requirements for independence under the Nasdaq Stock Market listing
standards and SEC rules and regulations. Each member of the Compensation Committee is also a nonemployee director, as defined pursuant
to Rule 16b-3 promulgated under the Exchange Act. The purpose of our Compensation Committee is to discharge the responsibilities of our
Board relating to compensation of our executive officers. Our Compensation Committee, among other things:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#9679;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">reviews,
                                            approves and determines the compensation of our executive officers;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#9679;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">administers
                                            our stock and equity incentive plans;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#9679;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">makes
                                            recommendations to our Board regarding director compensation and the establishment and terms
                                            of incentive compensation and equity plans; and</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#9679;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">establishes
                                            and reviews general policies relating to compensation and benefits of our employees.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">Our
chief executive officer may, from time to time, provide input and recommendations to our Compensation Committee concerning the compensation
of our other executive officers. Our chief executive officer may also, from to time, attend Compensation Committee meetings, but he is
not present during the Committee&rsquo;s deliberations regarding his own compensation. Our Compensation Committee operates under a written
charter that satisfies the applicable rules of the SEC and the listing standards of the Nasdaq Stock Market. During the year ended December
31, 2021, our Compensation Committee met four times and acted by unanimous written consent one time.</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">Nominating
and Corporate Governance Committee</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">Our
Nominating and Corporate Governance Committee consists of Franklyn Prendergast and Vijay Chandru, with Dr. Prendergast acting as Chair.
The composition of our Nominating and Corporate Governance Committee meets the requirements for independence under Nasdaq Stock Market
listing standards and SEC rules and regulations and each member of our Nominating and Corporate Governance Committee is also a nonemployee
director, as defined pursuant to Rule 16b-3 promulgated under the Exchange Act. Our Nominating and Corporate Governance Committee, among
other things:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#9679;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">identifies,
                                            evaluates and makes recommendations to our Board regarding nominees for election to our Board
                                            and its committees;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#9679;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">evaluates
                                            the performance of our Board and of individual directors;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#9679;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">considers
                                            and makes recommendations to our Board regarding the composition of our Board and its committees;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in"></P>

<!-- Field: Page; Sequence: 14; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#9679;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">reviews
                                            developments in corporate governance practices;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#9679;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">evaluates
                                            the adequacy of our corporate governance practices and reporting; and</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#9679;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">develops
                                            and makes recommendations to our Board regarding corporate governance guidelines and matters.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">When evaluating director candidates,
our Nominating and Corporate Governance Committee seeks to ensure that our Board has the requisite skills and experience and that its
members consist of persons with appropriately complementary and independent backgrounds. The Nominating and Corporate Governance Committee
will consider all aspects of a candidate&rsquo;s qualifications in the context of Lantern&rsquo;s needs, including: industry experience,
preferably at an executive level; experience in the same business sector as that of the Company; subject matter expertise and operations
experience in areas important to the Company&rsquo;s growth and advancement; experience as an officer or director of a public company;
independence from management; practical business judgment; personal and professional integrity and ethics; and the ability to commit sufficient
time and attention to the activities of the Board, as well as the absence of any potential conflicts with our Company&rsquo;s interests.
While we do not have a formal diversity policy, we understand the desirability of having a Board comprised of directors with diverse and
varied backgrounds, experience and opinions, and as we look to expand our Board or replace retiring Board members our Nominating and Corporate
Governance Committee will place special emphasis on finding qualified candidates with diverse gender and ethnic backgrounds. However,
the Nominating and Corporate Governance Committee retains the right to modify these qualifications from time to time. Candidates for director
nominees are reviewed in the context of the current composition of the Board, the operating requirements of our Company, and the long-term
interests of our stockholders.</P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">Our
Nominating and Corporate Governance Committee will consider for directorship candidates nominated by third parties, including stockholders.
The Nominating and Corporate Governance Committee&rsquo;s consideration will take into account the comprehensive criteria for Board membership
determined by the Committee within the context of the needs of the Company at the time. At this time our Nominating and Corporate Governance
Committee does not have a policy with regard to the consideration of director candidates recommended by stockholders. The Nominating
and Corporate Governance committee believes that it is in the best position to identify, review, evaluate, and select qualified candidates
for Board membership, based on the comprehensive criteria for Board membership determined by the Committee. However, <FONT STYLE="background-color: white">pursuant
to the proxy access provisions of our bylaws, a stockholder, or group of up to 10 stockholders, that has owned continuously for at least
three years shares of our common stock representing an aggregate of at least 3% of our outstanding shares, may nominate and include in
our proxy materials director nominees constituting up to the greater of two or 20% of our Board, provided that the stockholder(s) and
nominee(s) satisfy the requirements in the proxy access provisions of our bylaws.</FONT></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">For a third party to suggest a
candidate, one should provide our corporate secretary, David Margrave, with the name of the candidate, together with a brief biographical
sketch and a document indicating the candidate&rsquo;s willingness to serve if elected. In the case of Dr. Maccecchini, she was recommended
to the Nominating and Corporate Governance Committee by the lead underwriter in our initial public offering.</P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">The
Nominating and Corporate Governance Committee operates under a written charter that satisfies the applicable listing requirements and
rules of the Nasdaq Stock Market. During the year ended December 31, 2021, our Nominating and Corporate Governance Committee met two
times.</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">Board
Leadership Structure and Role in Risk Oversight</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">Donald
Jeff Keyser serves as our chairman of the Board and Panna Sharma serves as our president and chief executive officer. We have neither
adopted a formal policy on whether the chairman and chief executive officer positions should be separate or combined nor do we have a
lead director. We believe that, given the small size of our Board and establishment of separate Audit, Compensation, and Nominating and
Corporate Governance Committees consisting of independent directors, our present Board structure is in the best interest of us and our
stockholders. Our Board has an active role in overseeing our areas of risk. While the full Board has overall responsibility for risk
oversight, the Board has assigned certain areas of risk primarily to designated committees, which report back to the full Board.</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 15; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">Process
for Stockholders to Send Communications to our Board of Directors</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">Because
we have always maintained open channels of communication with our stockholders, we do not have a formal policy that provides a process
for stockholders to send communications to our Board. However, if a stockholder would like to send a communication to our Board, please
address the letter to the attention of our corporate secretary, David R. Margrave, and it will be distributed to each director.</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">Employee,
Officer and Director Hedging</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">We
have adopted a policy that no director, officer, or designated employees of Lantern may engage in any short term or speculative transactions,
involving securities of the Company, unless advance approval is obtained from the Company&rsquo;s compliance officer. These prohibited
speculative transactions include short sales, publicly traded options, hedging transactions, margin accounts, and pledged securities.</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">Compensation
Committee Interlocks and Insider Participation</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">None
of our independent directors, Donald Jeff Keyser, Vijay Chandru, Leslie W. Kreis, Jr., Franklyn Prendergast and David S. Silberstein,
is currently or has been at any time one of our officers or employees. Our Board nominee Maria Maccecchini is not currently and has not
been at any time one of our officers or employees. None of our executive officers currently serves, or has served during the last year,
as a member of the board or compensation committee of any entity that has one or more executive officers serving as a member of our Board.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">We
have adopted a code of conduct for all employees, including the chief executive officer, principal financial officer and principal accounting
officer or controller, and/or persons performing similar functions, which is available on our investor relations website located at <I>ir.lanternpharma.com/corporate-governance/governance-documents</I>.</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">Limitation
of Liability of Directors and Indemnification of Directors and Officers</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">The
Delaware General Corporation Law provides that corporations may include a provision in their certificate of incorporation relieving directors
of monetary liability for breach of their fiduciary duty as directors, provided that such provision shall not eliminate or limit the
liability of a director (i) for any breach of the director&rsquo;s duty of loyalty to the corporation or its stockholders, (ii) for acts
or omissions not in good faith or which involve intentional misconduct or a knowing violation of law, (iii) for unlawful payment of a
dividend or unlawful stock purchase or redemption, or (iv) for any transaction from which the director derived an improper personal benefit.
Our certificate of incorporation provides that directors are not liable to us or our stockholders for monetary damages for breach of
their fiduciary duty as directors to the fullest extent permitted by Delaware law. In addition to the foregoing, our certificate of incorporation
provides that we shall indemnify directors, officers, employees or agents to the fullest extent permitted by law and we have agreed to
provide such indemnification to each of our executive officers and directors by way of written indemnification agreements.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">The
above provisions in our certificate of incorporation and bylaws and in the written indemnification agreements may have the effect of
reducing the likelihood of derivative litigation against directors and may discourage or deter stockholders or management from bringing
a lawsuit against directors for breach of their fiduciary duty, even though such an action, if successful, might otherwise have benefited
us and our stockholders. However, we believe that the foregoing provisions are necessary to attract and retain qualified persons as directors.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">Insofar
as indemnification for liabilities arising under the Securities Act may be permitted to our directors, officers and controlling persons
pursuant to the foregoing provisions, or otherwise, we have been advised that in the opinion of the SEC, such indemnification is against
public policy as expressed in the Securities Act and is, therefore, unenforceable.</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 16; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->
<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in"><A NAME="a_006"></A>PROPOSAL NO. 2<BR>
RATIFICATION OF APPOINTMENT OF<BR>
INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Audit Committee has appointed
EisnerAmper LLP (which we refer to as &ldquo;Eisner&rdquo;) as our independent registered public accounting firm for the year ending December
31, 2022, and our Board has directed that management submit the appointment of Eisner as our independent registered public accounting
firm for ratification by the stockholders at the Annual Meeting. A representative of Eisner is expected to be available at the Annual
Meeting and will have an opportunity to make a statement if he or she so desires and will be available to respond to appropriate questions.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Stockholder ratification of
the selection of Eisner as our independent registered public accountants is not required by our Bylaws or otherwise. However, our Board
is submitting the appointment of Eisner to the stockholders for ratification as a matter of corporate practice. If the stockholders fail
to ratify the appointment, the Audit Committee will reconsider whether or not to retain Eisner. Even if the selection is ratified, the
Audit Committee, in its discretion, may direct the appointment of a different independent registered public accountant at any time during
the year if the Audit Committee determines that such a change would be in the Company&rsquo;s and our stockholders&rsquo; best interests.</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">Board Recommendation</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center">OUR BOARD RECOMMENDS
A VOTE &ldquo;FOR&rdquo; THE RATIFICATION OF EISNERAMPER LLP<BR>
AS OUR INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM<BR>
FOR THE FISCAL YEAR ENDING DECEMBER 31, 2022</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">Fees Incurred for Services by Principal Accountant</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The following table sets forth
the aggregate fees billed to us for services rendered to us for the years ended December 31, 2021 and 2020 by our independent registered
public accounting firm, EisnerAmper LLP and their affiliates.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2021</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2020</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 76%; text-align: left"><FONT STYLE="font-size: 10pt">Audit Fees<SUP>(A)</SUP></FONT></TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 9%; text-align: right">140,465</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 9%; text-align: right">170,560</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">Audit&nbsp;&ndash; Related Fees</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&mdash;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&mdash;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-bottom: 1.5pt">Tax Fees</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">13,360</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">11,400</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-bottom: 4pt">&nbsp;</TD><TD STYLE="padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 4pt double; text-align: right">153,825</TD><TD STYLE="padding-bottom: 4pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 4pt double; text-align: right">181,960</TD><TD STYLE="padding-bottom: 4pt; text-align: left">&nbsp;</TD></TR>
  </TABLE>


<P STYLE="margin: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0in"></TD><TD STYLE="width: 0.25in; text-align: left">(A)</TD><TD STYLE="text-align: justify">The audit fee consisted of fees for the audit of our financial
statements, the review of the interim financial statements included in our quarterly reports on Form&nbsp;10-Q, and other professional
services provided in connection with the statutory and regulatory filings or engagements and capital market financings.</TD>
</TR></TABLE>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">Pre-Approval Policies and Procedures</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Audit Committee has responsibility
for selecting, appointing, evaluating, compensating, retaining and overseeing the work of the independent registered public accounting
firm. In recognition of this responsibility, the Audit Committee has established policies and procedures in its charter regarding pre-approval
of any audit and non-audit service provided to the Company by the independent registered public accounting firm and the fees and terms
thereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Audit Committee considered
the compatibility of the provision of other services by its registered public accountant with the maintenance of their independence. The
Audit Committee approved all audit and tax services provided by Eisner in 2021 and 2020. Eisner did not perform any non-audit services
in 2021 or 2020, other than the tax services discussed above.</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 17; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">Audit Committee Report</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Audit Committee issued
the following report for inclusion in this Proxy Statement and our 2021 Annual Report:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">&#9679;</TD><TD STYLE="text-align: justify">The Audit Committee has reviewed and discussed the audited consolidated financial statements for the year
ended December 31, 2021 with management of Lantern Pharma Inc. and with Lantern Pharma Inc.&rsquo;s independent registered public accounting
firm, EisnerAmper LLP.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">&#9679;</TD><TD STYLE="text-align: justify">The Audit Committee has discussed with EisnerAmper LLP those matters required by Statement on Auditing
Standards No. 1301, &ldquo;Communications with Audit Committee,&rdquo; as adopted by the Public Company Accounting Oversight Board (&ldquo;PCAOB&rdquo;).</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">&#9679;</TD><TD STYLE="text-align: justify">The Audit Committee has received and reviewed the written disclosures and the letter from EisnerAmper
LLP required by the PCAOB regarding EisnerAmper LLP&rsquo;s communications with the Audit Committee concerning the accountant&rsquo;s
independence and has discussed with EisnerAmper LLP its independence from Lantern Pharma Inc. and its management.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Based on the review and discussions
referenced in paragraphs 1 through 3 above, the Audit Committee recommended to our Board that the audited financial statements for the
year ended December 31, 2021 be included in the Annual Report on Form 10-K for that year for filing with the SEC.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 60%">
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P></TD>
    <TD STYLE="width: 40%">
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">AUDIT COMMITTEE</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Donald Jeff Keyser</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Vijay Chandru</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Franklyn Prendergast</P></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<!-- Field: Page; Sequence: 18; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in"><A NAME="a_005"></A>PROPOSAL NO. 3<BR>
APPROVE AN ADJOURNMENT OF THE ANNUAL MEETING, IF NECESSARY,<BR>
TO SOLICIT ADDITIONAL PROXIES IF THERE ARE NOT SUFFICIENT VOTES IN FAVOR<BR>
OF PROPOSALS 1 OR 2</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">Introduction</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">As described above, our Board
has recommended the election of six (6) directors to serve for the ensuing year as members of the Board (Proposal 1), and ratification
of the appointment of EisnerAmper LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2022
(Proposal 2). In furtherance of these recommendations, we are asking our stockholders to approve an adjournment of the Annual Meeting,
if necessary, to solicit additional proxies if there are not sufficient votes in favor of Proposals 1 or 2.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Proposal 3, to approve an
adjournment of the Annual Meeting, if necessary, to solicit additional proxies if there are not sufficient votes in favor of Proposals
1 or 2, will require the affirmative vote of a majority of the votes present and entitled to vote at the Annual Meeting with respect to
such matter.</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">Board Recommendation</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center">OUR BOARD RECOMMENDS
A VOTE &ldquo;FOR&rdquo; THE APPROVAL OF AN ADJOURNMENT OF THE ANNUAL MEETING, IF NECESSARY, TO SOLICIT ADDITIONAL PROXIES IF THERE ARE
NOT SUFFICIENT VOTES IN FAVOR OF PROPOSALS 1 OR 2.</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in">&nbsp;</P>


<!-- Field: Page; Sequence: 19; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in"><A NAME="a_007"></A>SECURITY OWNERSHIP OF CERTAIN
BENEFICIAL OWNERS AND MANAGEMENT<BR>
AND RELATED STOCKHOLDER MATTERS</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The following table sets forth,
as of April 15, 2022, information concerning the beneficial ownership of shares of our common stock held by our directors, director nominees
and our named executive officers, our directors, director nominees and executive officers as a group, and each person known by us to be
a beneficial owner of more than 5% of our outstanding common stock. Unless otherwise indicated, the business address of each of our directors,
director nominees, executive officers and beneficial owners of more than 5% of our outstanding common stock is c/o Lantern Pharma Inc.,
1920 McKinney Avenue, 7<SUP>th</SUP> Floor, Dallas, Texas 75201. Each person has sole voting and investment power with respect to the
shares of our common stock, except as otherwise indicated. Beneficial ownership consists of a direct interest in the shares of common
stock, except as otherwise indicated.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">As used in this section, the
term &ldquo;beneficial ownership&rdquo; with respect to a security is defined by Rule 13d-3 under the Securities Exchange Act of 1934,
as amended, as consisting of sole or shared voting power (including the power to vote or direct the vote) and/or sole or shared investment
power (including the power to dispose of or direct the disposition of) with respect to the security through any contract, arrangement,
understanding, relationship or otherwise, subject to community property laws where applicable. Beneficial ownership also includes the
number of shares that a person has the right to acquire within 60 days, pursuant to the exercise of options or warrants or the conversion
of notes, debentures or other indebtedness. Two or more persons might count as beneficial owners of the same share.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">There were approximately 12
holders of record of our shares of common stock as of the date of this Proxy Statement. The number of holders does not include individual
participants in security positions listings.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="6" STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Shares Beneficially <BR> Owned</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="border-bottom: Black 1.5pt solid; font-weight: bold"><FONT STYLE="font-size: 10pt"><B>Name and Address of Beneficial Owner<SUP>(1)</SUP></B></FONT></TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Number</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Percent</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="font-style: italic">Officers and Directors</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD><TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD><TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 76%; text-align: left"><FONT STYLE="font-size: 10pt">Panna Sharma, Chief Executive Officer, President, and Director<SUP>(2)</SUP></FONT></TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 9%; text-align: right">475,038</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 9%; text-align: right">4.2</TD><TD STYLE="width: 1%; text-align: left">%</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 10pt">David R. Margrave, Chief Financial Officer and Secretary<SUP>(3)</SUP></FONT></TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">62,495</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 10pt">*</FONT></TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 10pt">Kishor G. Bhatia, Chief Scientific Officer<SUP>(4)</SUP></FONT></TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">41,661</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 10pt">*</FONT></TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 10pt">Leslie W. Kreis, Jr., Director<SUP>(5)</SUP></FONT></TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">1,974,933</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">18.0</TD><TD STYLE="text-align: left">%</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 10pt">Donald J. Keyser, Chairman of the Board<SUP>(6)</SUP></FONT></TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">84,746</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 10pt">*</FONT></TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 10pt">David S. Silberstein, Director<SUP>(7)</SUP></FONT></TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">11,546</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 10pt">*</FONT></TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 10pt">Vijay Chandru, Director<SUP>(8)</SUP></FONT></TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">6,449</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 10pt">*</FONT></TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 10pt">Franklyn Prendergast, Director<SUP>(8)</SUP></FONT></TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">6,449</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 10pt">*</FONT></TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">Maria Maccecchini, Director Nominee</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">0</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 10pt">*</FONT></TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-style: italic; text-align: left">All Officers, Directors and Nominees as a group (9 people)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">2,663,317</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">23.0</TD><TD STYLE="text-align: left">%</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-style: italic">5% Stockholders</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 10pt">Bios Equity Entities<SUP>(9)</SUP></FONT></TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">1,969,100</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">18.0</TD><TD STYLE="text-align: left">%</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 10pt">Biological Mimetics, Inc.<SUP>(10)</SUP></FONT></TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">958,265</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">8.9</TD><TD STYLE="text-align: left">%</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD><FONT STYLE="font-size: 10pt">GPGV Entities<SUP>(11)</SUP></FONT></TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">614,284</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">5.7</TD><TD STYLE="text-align: left">%</TD></TR>
  </TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Rule-Page --><DIV STYLE="margin-top: 0; margin-bottom: 0; width: 25%"><DIV STYLE="font-size: 1pt; border-top: Black 1.5pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">*</TD><TD STYLE="text-align: justify">Represents less than 1% of shares outstanding.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">(1)</TD><TD STYLE="text-align: justify">All addresses above are 1920 McKinney Avenue, 7th Floor, Dallas, Texas 75201, unless otherwise stated.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in"></P>

<!-- Field: Page; Sequence: 20; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->16<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">(2)</TD><TD STYLE="text-align: justify">Consists of 475,038 shares of common stock subject to options exercisable within 60 days. Excludes 20,450
shares of common stock underlying options which are subject to vesting conditions.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">(3)</TD><TD STYLE="text-align: justify">Consists of 62,495 shares of common stock subject to options exercisable within 60 days. Excludes 41,905
shares of common stock underlying options which are subject to vesting conditions.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">(4)</TD><TD STYLE="text-align: justify">Consists of 41,661 shares of common stock subject to options exercisable within 60 days. Excludes 27,939
shares of common stock underlying options which are subject to vesting conditions.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">(5)</TD><TD STYLE="text-align: justify">Consists of (i) 1,969,100 shares of common stock beneficially owned by Messrs. Kreis and Fletcher as described
in footnote 9, and (ii) 5,833 shares of common stock subject to options exercisable within 60 days. Excludes 3,302 shares of common stock
underlying options which are subject to vesting conditions. Mr. Kreis is the managing partner and co-founder of Bios Equity Partners,
LP and Bios Equity Partners II, LP.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">(6)</TD><TD STYLE="text-align: justify">Consists of (i) 38,987 shares of common stock subject to options exercisable within 60 days, (ii) 41,927
shares of common stock, and (iii) 3,832 shares of common stock issuable upon exercise of warrants. Excludes 5,886 shares of common stock
underlying options which are subject to vesting conditions.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">(7)</TD><TD STYLE="text-align: justify">Consists of 11,546 shares subject to options exercisable within 60 days. Excludes 5,886 shares of common
stock underlying options which are subject to vesting conditions. Dr. Silberstein is a director of Biological Mimetics, Inc. Dr. Silberstein
disclaims any beneficial ownership in the shares of our common stock held by Biological Mimetics, Inc.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">(8)</TD><TD STYLE="text-align: justify">Consists of 6,449 shares of common stock subject to options exercisable within 60 days. Excludes 5,886
shares of common stock underlying options which are subject to vesting conditions.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">(9)</TD><TD STYLE="text-align: justify">Consists of (i) 564,038 shares of common stock held by Bios Fund I,
LP (&ldquo;Bios Fund I&rdquo;), (ii) 329,904 shares of common stock held by Bios Fund I QP, LP (&ldquo;Bios Fund I QP&rdquo;), (iii) 668,738
shares of common stock held by Bios Fund II QP, LP (&ldquo;Bios Fund II QP&rdquo;), (iv) 54,873 shares of common stock issuable to Bios
Fund II QP upon exercise of warrants, (v) 204,723 shares of common stock held by Bios Fund II, LP (&ldquo;Bios Fund II&rdquo;), (vi) 16,801
shares of common stock issuable to Bios Fund II upon exercise of warrants, (vii) 89,522 shares of common stock held by Bios Fund II NT,
LP (&ldquo;Bios Fund II NT&rdquo;), (viii) 7,347 shares of common stock issuable to Bios Fund II NT upon exercise of warrants, and (ix)
33,154 shares of common stock subject to options exercisable within 60&nbsp;days by BP Directors, LP (&ldquo;Bios Directors&rdquo;). Excludes
2,584 shares of common stock underlying options issued to Bios Directors which are subject to vesting conditions. Bios Equity Partners,
LP (&ldquo;Bios Equity I&rdquo;) is the general partner of the following entities: Bios Fund I, Bios Fund I QP, and Bios Directors. Bios
Equity Partners II, LP (&ldquo;Bios Equity II&rdquo;) is the general partner of Bios Fund II QP, Bios Fund II, and Bios Fund II NT. Cavu
Management, LP, an entity managed and controlled by Mr. Kreis, our director, and Bios Capital Management, LP, an entity managed and controlled
by Mr. Aaron Fletcher, are the general partners of Bios Equity I and Bios Equity II. Cavu Advisors LLC, an entity that is managed and
controlled by Mr. Kreis, is the general partner of Cavu Management LP. Bios Advisors GP, LLC, an entity that is managed and controlled
by Mr. Fletcher, is the general partner of Bios Capital Management, LP. The shares owned by Bios Fund I, Bios Fund I QP, Bios Fund II,
Bios Fund II QP, Bios Fund II NT and Bios Directors (&ldquo;Bios Equity Entities&rdquo;) are aggregated for purposes of reporting share
ownership information. Mr. Kreis and Mr. Fletcher share voting and investment control with respect to shares held by the Bios Equity Entities.
The address for the Bios Equity Entities is 1751 River Run, Suite 400, Fort Worth, Texas 76107.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">(10)</TD><TD STYLE="text-align: justify">Consists of 958,265 shares of common stock. Address is 124 Byte Drive, Frederick, Maryland 21702.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">(11)</TD><TD STYLE="text-align: justify">Consists of (i) 313,965 shares of common stock held by GPG LPI Investment, LLC, (ii) 131,697 shares of
common stock held by Lantern 3-19 Investment, LLC, (iii) 15,805 shares of common stock issuable to Lantern 3-19 Investment, LLC upon exercise
of warrants, and (iv) 152,817 shares of common stock held by Health Wildcatters Fund II, LLC. Green Park &amp; Golf Ventures, LLC (&ldquo;GPGV
I&rdquo;) is the managing member of the following entities: GPG LPI Investment, LLC and Health Wildcatters Fund II, LLC. Green Park &amp;
Golf Ventures II, LLC (&ldquo;GPGV II&rdquo;) is the managing member of Lantern 3-19 Investment, LLC. GPGV I and GPGV II are managed by
Clay M. Heighten, MD, Carl D. Soderstrom and Gilbert G. Garcia II. The shares owned by Lantern 3-19 Investment, LLC, GPG LPI Investment,
LLC, and Health Wildcatters Fund II, LLC (&ldquo;GPGV Entities&rdquo;) are aggregated for purposes of reporting share ownership information.
Dr. Heighten and Messrs. Soderstrom and Garcia share voting and investment control with respect to the shares held by the GPGV Entities.
The address for the GPGV Entities is 5910 N. Central Expressway, Suite 1400 Dallas, Texas 75206.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>


<!-- Field: Page; Sequence: 21; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->17<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in"><A NAME="a_008"></A>EXECUTIVE OFFICERS AND COMPENSATION</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">Executive Officers</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The following sets forth information
regarding the current executive officers of the Company. Biographical information pertaining to Panna Sharma, whom is both a director
and an executive officer of the Company, may be found in the section above entitled &ldquo;Proposal No. 1, Election of Directors-Information
about Director Nominees.&rdquo;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: left; border-bottom: Black 1.5pt solid; padding-bottom: 1.5pt; width: 30%; vertical-align: bottom">
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Name</B></P></TD>
    <TD STYLE="padding-bottom: 1.5pt; white-space: nowrap; width: 1%">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; width: 5%; text-align: center"><FONT STYLE="font-size: 10pt"><B>Age</B></FONT></TD>
    <TD STYLE="padding-bottom: 1.5pt; white-space: nowrap; width: 1%">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; width: 63%; text-align: center"><FONT STYLE="font-size: 10pt"><B>Position</B></FONT></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: #CCEEFF">
    <TD><FONT STYLE="font-size: 10pt">Panna Sharma</FONT></TD>
    <TD STYLE="white-space: nowrap">&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 10pt">51</FONT></TD>
    <TD STYLE="white-space: nowrap">&nbsp;</TD>
    <TD><FONT STYLE="font-size: 10pt">Chief Executive Officer, President and Director</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD><FONT STYLE="font-size: 10pt">David R. Margrave</FONT></TD>
    <TD STYLE="white-space: nowrap">&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 10pt">62</FONT></TD>
    <TD STYLE="white-space: nowrap">&nbsp;</TD>
    <TD><FONT STYLE="font-size: 10pt">Chief Financial Officer and Secretary</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: #CCEEFF">
    <TD><FONT STYLE="font-size: 10pt">Kishor G. Bhatia</FONT></TD>
    <TD STYLE="white-space: nowrap">&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 10pt">67</FONT></TD>
    <TD STYLE="white-space: nowrap">&nbsp;</TD>
    <TD><FONT STYLE="font-size: 10pt">Chief Scientific Officer</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><I>David R. Margrave</I> has
served as our Chief Financial Officer since November 2019 and as our Secretary since June 2018. Since January 2016, Mr. Margrave has served
as a life science consultant, providing strategic advisory and legal services to growing life science companies. From January 1995 to
December 2015, he served as an executive officer at BioNumerik Pharmaceuticals, Inc., a life science company focused on advancing innovative
cancer therapies. During his time at BioNumerik Pharmaceuticals, Inc., Mr. Margrave served in various positions including service as President
and as Chief Administrative Officer and General Counsel. Mr. Margrave has served as a consultant to BioNumerik Pharmaceuticals, Inc. since
January 2016. From April 2015 to December 2016, he also served as Senior Legal Advisor to MedCare Investment Corporation, a private investment
firm investing in the medical and healthcare services industries. Prior to joining BioNumerik Pharmaceuticals, Inc., Mr. Margrave was
a partner at Andrews &amp; Kurth LLP, a national law firm. Mr. Margrave serves as Chairman and a board member of the Texas Healthcare
and Bioscience Institute and as Chairman and a board member of the State of Texas Product Development&nbsp;&amp; Small Business Incubator
Board. He is a past board member of the Texas Technology Transfer Association. Mr. Margrave received a Bachelor of Arts and Science degree
in Economics and in Petroleum Engineering from Stanford University, and a J.D. degree from The University of Texas School of Law.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><I>Kishor G. Bhatia</I> has
served as our Chief Scientific Officer since December 2019, and as our scientific consultant since January 2019. Dr. Bhatia has also served
as a scientific consultant to Reprocell, one of our collaborators, since December 2016, and served as a scientific consultant to Cancer
Genetics, Inc. from December 2016 until November 2019. Since 2006, he has been employed as an Adjunct Investigator with the National Cancer
Institute-Division of Cancer Epidemiology and Genetics. From January 2007 until July 2016, Dr. Bhatia also served as a Director-AIDS Malignancy
Program at the National Cancer Institute-Office of HIV and AIDS Malignancy, and from January 2004 through January 2007, he served as a
Program Director and the Director of HIV and Cancer at the National Cancer Institute-Division of Cancer Treatment and Diagnosis. Dr. Bhatia
received a Bachelor of Science degree in microbiology from the University of Pune and a Ph.D. in biochemistry from the University of Mumbai
and is a Fellow of the Royal College of Pathology in the United Kingdom and was a Post-Doctoral Fellow at Johns Hopkins University and
a Research Assistant Professor at Georgetown University from 1985 to 1989.</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 22; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->18<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">Summary Compensation Table</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The following table sets forth
information concerning all forms of compensation earned by our named executive officers during the fiscal years ended December 31, 2021
and 2020 for services provided to the company and its subsidiaries, which compensation exceeded $100,000.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="padding-left: 0.125in; text-indent: -0.125in; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.25in; text-indent: -1.25in"><B>&nbsp;</B></P><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.25in; text-indent: -1.25in"><B>Name and Principal Position</B></P></TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Year</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Salary <BR> ($)</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Bonus <BR> ($)</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><FONT STYLE="font-size: 10pt"><B>Option&nbsp;Awards <BR> ($)<SUP>(4)</SUP></B></FONT></TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Total <BR> ($)</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 0.125in; text-indent: -0.125in; width: 41%; text-align: left">Panna Sharma,</TD><TD STYLE="width: 1%; font-weight: bold">&nbsp;</TD>
    <TD STYLE="width: 9%; font-weight: bold; text-align: center">2021</TD><TD STYLE="width: 1%; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 9%; text-align: right">432,000</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 9%; text-align: right">190,000</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 9%; text-align: right">-</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 9%; text-align: right">622,000</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 0.25in; text-indent: -0.125in; text-align: left"><FONT STYLE="font-size: 10pt">Chief&nbsp;Executive Officer and&nbsp;President<SUP>(1)&nbsp;</SUP></FONT></TD><TD STYLE="font-weight: bold">&nbsp;</TD>
    <TD STYLE="font-weight: bold; text-align: center">2020</TD><TD STYLE="font-weight: bold; text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">384,492</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">366,000</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">843,674</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">1,594,166</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 0.125in; text-indent: -0.125in">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 0.125in; text-indent: -0.125in; text-align: left">David R. Margrave,</TD><TD STYLE="font-weight: bold">&nbsp;</TD>
    <TD STYLE="font-weight: bold; text-align: center">2021</TD><TD STYLE="font-weight: bold; text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">300,000</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">66,000</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">195,315</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">561,315</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 0.25in; text-indent: -0.125in; text-align: left"><FONT STYLE="font-size: 10pt">Chief Financial Officer and Secretary<SUP>(2)&nbsp;</SUP></FONT></TD><TD STYLE="font-weight: bold">&nbsp;</TD>
    <TD STYLE="font-weight: bold; text-align: center">2020</TD><TD STYLE="font-weight: bold; text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">225,154</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">73,725</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">862,083</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">1,160,962</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 0.125in; text-indent: -0.125in">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 0.125in; text-indent: -0.125in; text-align: left">Kishor Bhatia, Ph.D.,</TD><TD STYLE="font-weight: bold">&nbsp;</TD>
    <TD STYLE="font-weight: bold; text-align: center">2021</TD><TD STYLE="font-weight: bold; text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">127,928</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">24,000</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">130,212</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">282,140</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 0.25in; text-indent: -0.125in; text-align: left"><FONT STYLE="font-size: 10pt">Chief Scientific Officer<SUP>(3)</SUP></FONT></TD><TD STYLE="font-weight: bold">&nbsp;</TD>
    <TD STYLE="font-weight: bold; text-align: center">2020</TD><TD STYLE="font-weight: bold; text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">82,385</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">10,501</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">574,722</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">667,608</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  </TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Rule-Page --><DIV STYLE="margin-top: 0; margin-bottom: 0; width: 25%"><DIV STYLE="font-size: 1pt; border-top: Black 1.5pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in; text-align: left">(1)</TD><TD STYLE="text-align: justify">Mr. Sharma began serving as our Chief Executive and President
on July 26, 2018 and as a director on August 29, 2018.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in; text-align: left">(2)</TD><TD STYLE="text-align: justify">Mr. Margrave began serving as our Chief Financial Officer in
November 2019 and as our Secretary in June 2018.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in; text-align: left">(3)</TD><TD STYLE="text-align: justify">Dr. Bhatia began serving as an employee of the company in June
2020. Dr. Bhatia provided services to the company in 2020 as a consultant prior to becoming an employee. The 2020 salary amount in the
table above includes $27,000 in compensation for consulting services paid to Dr. Bhatia in 2020.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in; text-align: left">(4)</TD><TD STYLE="text-align: justify">For 2021, the fair value of each option granted was estimated
using the Black-Scholes option-pricing model using the following weighted average assumptions: term between 5.6 and 6.3 years, risk free
rate of between 1.3% and 1.4%, volatility of between 90.3% and 90.6%, and dividend yield of 0.0%. Based on these assumptions, the grant
date fair value is between $7.40 and $7.70 per option share. For 2020, the fair value of each option granted was estimated using the
Black-Scholes option-pricing model using the following weighted average assumptions: term of 7 years, risk free rate of .54%, volatility
of 83.2%, and dividend yield of 0.0%. Based on these assumptions, the grant date fair value is $11.01 per option share. .</TD>
</TR></TABLE>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">Narrative Disclosure to Summary Compensation Table</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We have entered into written
employment agreements with the named executive officers, as described below. Each of our named executive officers has also executed our
standard form of confidential information and invention assignment agreement.</P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0">Employment Agreement with Panna Sharma</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We entered into an employment
agreement with Mr. Sharma on July 23, 2018, that governs the terms of his employment with us as Chief Executive Officer and President.
During the term of the agreement, which has been extended to July 30, 2022, Mr. Sharma was initially entitled to an annual base salary
of $260,000, which was increased to $320,000 in November 2019. Mr. Sharma&rsquo;s annual base salary increased to $432,000 upon completion
of our initial public offering and listing of our common stock on the NASDAQ Stock Market. In January 2022, the agreement was amended
to increase Mr. Sharma&rsquo;s annual base salary to $449,280, reflecting a 4% cost of living adjustment. Mr. Sharma received a cash bonus
of $366,000 for fiscal year 2020 and a cash bonus of $190,00 for fiscal year 2021. In addition, Mr. Sharma will be entitled to an annual
cash bonus equal to 25% of his annual base salary in future years, subject to the Company achieving certain operational and strategic
milestones to be mutually agreed upon by the Board and Mr. Sharma and to additional discretionary bonuses to be determined by the Compensation
Committee.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">As incentive
compensation, on June 15, 2020 Mr. Sharma was granted stock options to purchase 76,628 shares of our common stock under the terms
and conditions of our 2018 Equity Incentive Plan. The exercise price for these options is $15.00 per share. One third of these
options vested 180 days after the grant date with the remaining two thirds of the options vesting in equal monthly increments over a
thirty (30) month period commencing the 181<SUP>st</SUP> day after the grant date.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Mr. Sharma also has the right
to participate in the health insurance, vacation and other employee benefit plans and programs generally provided by us to our executive
employees in effect from time to time.</P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 23; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->19<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0">Employment Agreement with David Margrave</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We have entered into an employment
agreement with Mr. Margrave that governs the terms of his employment with us as our Chief Financial Officer. The term of the agreement
ends on July 30, 2022. From commencement of the agreement in June 2020 through December 31, 2021, Mr. Margrave received an annual base
salary of $300,000. In January 2022, the agreement was amended to increase Mr. Margrave&rsquo;s annual base salary to $312,000, reflecting
a 4% cost of living adjustment. In 2020, Mr. Margrave received a signing bonus of $32,500 and also received a cash performance bonus of
$41,225. Mr. Margrave received a cash performance bonus of $66,000 in 2021. In addition, Mr. Margrave will be entitled to an annual cash
bonus equal to 10% of his annual base salary in future years, subject to the Company achieving certain operational and strategic milestones
to be mutually agreed upon by the CEO and Mr. Margrave.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">As incentive compensation,
on June 15, 2020 Mr. Margrave was granted stock options to purchase 78,300 shares of our common stock under the terms and conditions of
our 2018 Equity Incentive Plan. The exercise price for these options is $15.00 per share. One third of these options vested 180 days from
the grant date, with the remaining two thirds of the options vesting in equal monthly increments over the period commencing the 181<SUP>st</SUP>
day after the grant date and ending 30 months thereafter (or 36 months after the grant date). As incentive compensation, on October 29,
2021 Mr. Margrave was granted stock options to purchase 26,100 shares of our common stock under the terms and conditions of our 2018 Equity
Incentive Plan. The exercise price for these options is $10.21 per share. The options vest and first become exercisable in equal monthly
increments over a 36-month period commencing November 29, 2021.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Mr. Margrave also has the
right to participate in the health insurance, vacation and other employee benefit plans and programs generally provided by us to our executive
employees in effect from time to time.</P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0">Employment Agreement with Kishor G. Bhatia, Ph.D.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We have entered into an employment
agreement with Dr. Bhatia that governs the terms of his employment with us as our Chief Scientific Officer. The term of the agreement
ends on July 30, 2022. From commencement of the agreement in June 2020 until March 4, 2021, the employment agreement provided for Dr.
Bhatia to provide a minimum of 20 hours per week as our Chief Scientific Officer and be entitled to an annual base salary of $100,000.
The employment agreement with Dr. Bhatia was amended on March 4, 2021. The amended agreement provided for Dr. Bhatia to provide a minimum
of 26.67 hours per week as our Chief Scientific Officer and be entitled to an annual base salary of $133,333. In January 2022, the agreement
was amended to increase Dr. Bhatia&rsquo;s annual base salary to $138,666, reflecting a 4% cost of living adjustment. Dr. Bhatia received
a cash performance bonus of $10,501 in 2020 and a cash performance bonus of $24,000 in 2021. In addition, Dr. Bhatia will be entitled
to an annual cash bonus equal to 10% of his annual base salary in future years, subject to the Company achieving certain operational and
strategic milestones to be mutually agreed upon by the CEO and Dr. Bhatia.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">As incentive compensation,
on June 15, 2020 Dr. Bhatia was granted stock options to purchase 52,200 shares of our common stock under the terms and conditions of
our 2018 Equity Incentive Plan. The exercise price for these options is $15.00 per share. One third of these options vested 180 days from
the grant date, with the remaining two thirds of the options vesting in equal monthly increments over the period commencing the 181<SUP>st</SUP>
day after the grant date and ending 30 months thereafter (or 36 months after the grant date). As incentive compensation, on October 29,
2021 Dr. Bhatia was granted stock options to purchase 17,400 shares of our common stock under the terms and conditions of our 2018 Equity
Incentive Plan. The exercise price for these options is $10.21 per share. The options vest and first become exercisable in equal monthly
increments over a 36-month period commencing November 29, 2021.</P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0">Potential Payments upon Termination and Change in Control</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Regardless of the manner in
which our named executive officers&rsquo; services terminate, each named executive officer is entitled to receive amounts earned during
their terms of service, including unpaid salary. In addition, each named executive officer is eligible to receive certain benefits pursuant
to their employment agreement with us, as described below.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 24; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->20<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We or the named executive
officer may terminate their employment agreement upon 30 days&rsquo; notice to the other party. If the named executive officer is terminated
without cause, then the named executive officer will be entitled to severance pay in an amount equal to the greater of (i) his base salary
for the remainder of the term of the employment agreement or (ii) three months of his base salary. In addition, the named executive officer
shall be entitled to an amount equal to his annual bonus amount prorated through the date of termination, if such bonus is earned in the
calendar year of his termination. The foregoing payments are subject to the named executive officer entering into an agreement releasing
all claims against us. In addition, pursuant to the 2018 Equity Incentive Plan, in the event of a change in control, as defined in the
2018 Equity Incentive Plan, all unvested securities owned by a named executive officer shall immediately vest and remain exercisable for
the full term of the option. &ldquo;Cause&rdquo; is defined in the named executive officers&rsquo; employment agreements to include, but
not limited to, (i) a material breach of the named executive officers&rsquo; duties as an employee or obligations under their agreement,
subject to notice and an opportunity to cure such breach, (ii) a breach or threatened breach of the restrictive covenants and confidentiality
provisions under their agreement, (iii) a refusal or failure to follow the reasonable instructions from our Board of Directors, (iv) failure
to achieve any mutually agreed and specified material operational or strategic milestones, (v) a breach of any of our rules or policies
that is likely to have a material adverse effect on us, subject to notice and an opportunity to cure the breach, (vi) a material failure,
other than by reason of disability, to perform satisfactorily to the Board on a regular basis the duties as specified therein, subject
to notice and an opportunity to cure the failure, (vii) any intentional or grossly negligent act or omission that causes or threatens
to cause a material loss to us or our business, (viii) a commission of, indictment for, or conviction or plea of nolo contender to a crime
of moral turpitude or fraud, embezzlement or similar act of dishonesty or any violation of law or rule that materially impairs or injures
us or our reputation, and (ix) any appropriation of any business opportunity belonging to us for the named executive officers&rsquo; personal
benefit or the benefits of any family member or affiliated entity.</P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0">Benefit Plans</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We do not have any profit-sharing
plan or similar plans for the benefit of our officers, directors or employees. However, we may establish such plans in the future.</P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0">Perquisites, Health, Welfare and Retirement Benefits</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">All of our current named executive
officers are eligible to participate in our employee benefit plans, including health insurance for which we pay portions of the premiums,
in each case on the same basis as all of our other employees. We pay portions of the premiums for health insurance for all of our employees,
including our named executive officers. We generally do not provide perquisites or personal benefits to our named executive officers.</P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0">Nonqualified Deferred Compensation</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Our named executive officers
did not participate in, or earn any benefits under, a nonqualified deferred compensation plan sponsored by us during the fiscal year ended
December 31, 2021. Our board of directors may elect to provide our officers and other employees with nonqualified defined contribution
or other nonqualified deferred compensation benefits in the future if it determines that doing so is in our best interests.</P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0">Amended and Restated 2018 Equity Incentive Plan</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The 2018 Equity Incentive
Plan was adopted by the Board of Directors and approved by the stockholders on August 29, 2018, and most recently amended on August 19,
2020. The Company reserved 1,489,680 shares of common stock for issuance under the 2018 Equity Incentive Plan, of which options to purchase
905,826 shares of our common stock are outstanding as of the date of this proxy statement. In addition, as of the date of this Proxy Statement,
the Board of Directors has granted a restricted stock award of 68,512 shares pursuant to the 2018 Equity Incentive Plan.</P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 25; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->21<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0">Outstanding Equity Awards at December 31, 2021</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The following table sets forth
certain information concerning equity awards held by our named officers as of December 31, 2021:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="padding-left: 0.125in; text-indent: -0.125in; white-space: nowrap; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="white-space: nowrap; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="19" STYLE="white-space: nowrap; border-bottom: Black 1.5pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Option Awards</B></FONT></TD>
    <TD STYLE="white-space: nowrap; padding-bottom: 1.5pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="padding-left: 0.125in; text-indent: -0.125in; white-space: nowrap; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Name</B></FONT></TD>
    <TD STYLE="white-space: nowrap; padding-bottom: 1.5pt; text-align: center">&nbsp;</TD>
    <TD STYLE="white-space: nowrap; border-bottom: Black 1.5pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Award<BR>
Grant Date</B></FONT></TD>
    <TD STYLE="white-space: nowrap; padding-bottom: 1.5pt; text-align: center">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="white-space: nowrap; border-bottom: Black 1.5pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Number of<BR>
Securities<BR>
Underlying<BR>
Unexercised<BR>
Options<BR>
Exercisable</B></FONT></TD>
    <TD STYLE="white-space: nowrap; padding-bottom: 1.5pt; text-align: center">&nbsp;</TD>
    <TD STYLE="white-space: nowrap; padding-bottom: 1.5pt; text-align: center">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="white-space: nowrap; border-bottom: Black 1.5pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Number of<BR>
Securities<BR>
Underlying<BR>
Unexercised<BR>
Options<BR>
Unexercisable</B></FONT></TD>
    <TD STYLE="white-space: nowrap; padding-bottom: 1.5pt; text-align: center">&nbsp;</TD>
    <TD STYLE="white-space: nowrap; padding-bottom: 1.5pt; text-align: center">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="white-space: nowrap; border-bottom: Black 1.5pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Equity<BR>
Incentive<BR>
Plan<BR>
Awards:<BR>
Number of<BR>
Securities<BR>
Underlying<BR>
Unexercised<BR>
Unearned<BR>
Options</B></FONT></TD>
    <TD STYLE="white-space: nowrap; padding-bottom: 1.5pt; text-align: center">&nbsp;</TD>
    <TD STYLE="white-space: nowrap; padding-bottom: 1.5pt; text-align: center">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="white-space: nowrap; border-bottom: Black 1.5pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Option<BR>
Exercise<BR>
Price <BR>
($)</B></FONT></TD>
    <TD STYLE="white-space: nowrap; padding-bottom: 1.5pt; text-align: center">&nbsp;</TD>
    <TD STYLE="white-space: nowrap; padding-bottom: 1.5pt; text-align: center">&nbsp;</TD>
    <TD STYLE="white-space: nowrap; border-bottom: Black 1.5pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Option<BR>
Expiration<BR>
Date</B></FONT></TD>
    <TD STYLE="white-space: nowrap; padding-bottom: 1.5pt; text-align: center">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: #CCEEFF">
    <TD STYLE="padding-left: 0.125in; text-indent: -0.125in; width: 31%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Panna Sharma,</B></FONT></TD>
    <TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 9%; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>8/29/2018</B></FONT></TD>
    <TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 9%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>199,558</B></FONT></TD>
    <TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 9%; text-align: right"></TD>
    <TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 9%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&mdash;</B></FONT></TD>
    <TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>$</B></FONT></TD>
    <TD STYLE="width: 9%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>1.03</B></FONT></TD>
    <TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 9%; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>8/28/2028</B></FONT></TD>
    <TD STYLE="width: 1%">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: #CCEEFF">
    <TD STYLE="padding-left: 0.125in; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Chief Executive Officer, and</B></FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>12/17/2018</B></FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>219,302</B></FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&mdash;</B></FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>$</B></FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>1.03</B></FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>12/16/2028</B></FONT></TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: #CCEEFF">
    <TD STYLE="padding-left: 0.25in; text-indent: -0.125in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>President<SUP>(1)(4)</SUP></B></FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>6/15/2020</B></FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>45,966</B></FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right"><B>30,662</B></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&mdash;</B></FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>$</B></FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>15.00</B></FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>6/14/2030</B></FONT></TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: white">
    <TD STYLE="padding-left: 0.125in; text-indent: -0.125in">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: #CCEEFF">
    <TD STYLE="padding-left: 0.125in; text-indent: -0.125in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>David Margrave,</B></FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;<B>6/15/2020</B></FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>46,980</B></FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>31,320</B></FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&mdash;</B></FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>$</B></FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>15.00</B></FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>6/14/2030</B></FONT></TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: #CCEEFF">
    <TD STYLE="padding-left: 0.125in; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Chief Financial Officer</B></FONT><B> and Secretary<SUP>(2)(4)</SUP></B></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>10/29/2021</B></FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>1,450</B></FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>24,650</B></FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&mdash;</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>$</B></FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>10.21</B></FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>10/28/2031</B></FONT></TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: white">
    <TD STYLE="padding-left: 0.125in; text-indent: -0.125in">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: #CCEEFF">
    <TD STYLE="padding-left: 0.125in; text-indent: -0.125in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Kishor Bhatia, Ph.D.</B></FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>6/15/2020</B></FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>31,320</B></FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>20,880</B></FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&mdash;</B></FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>$</B></FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>15.00</B></FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>6/14/2030</B></FONT></TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: #CCEEFF">
    <TD STYLE="padding-left: 0.25in; text-indent: -0.125in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Chief Scientific Officer<SUP>(3)(4)</SUP></B></FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>10/29/2021</B></FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>966</B></FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>16,434</B></FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&mdash;</B></FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>$</B></FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>10.21</B></FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>10/28/2031</B></FONT></TD>
    <TD>&nbsp;</TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Rule-Page --><DIV STYLE="margin-top: 0; margin-bottom: 0; width: 25%"><DIV STYLE="font-size: 1pt; border-top: Black 1.5pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in; text-align: left">(1)</TD><TD STYLE="text-align: justify">Mr. Sharma began serving as our Chief Executive and President
on July 26, 2018 and as a director on August 29, 2018.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in; text-align: left">(2)</TD><TD STYLE="text-align: justify">Mr. Margrave began serving as our Chief Financial Officer in
November&nbsp;2019 and as our Secretary in June&nbsp;2018.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in; text-align: left">(3)</TD><TD STYLE="text-align: justify">Dr.&nbsp;Bhatia began serving as our Chief Scientific Officer
in December&nbsp;2019.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in; text-align: left">(4)</TD><TD STYLE="text-align: justify">No options were exercised by the above-named individuals in
2021 or 2020.</TD>
</TR></TABLE>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">Director Compensation</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Below is a summary of compensation
accrued or paid to our non-executive directors during the fiscal year ended December 31, 2021.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="border-bottom: Black 1.5pt solid; padding-bottom: 1.5pt"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Name</B></P></TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Fees <BR>
Earned or Paid in<BR>
 Cash ($)</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><FONT STYLE="font-size: 10pt"><B>Option Awards<SUP>(1)</SUP> <BR> ($)</B></FONT></TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Total <BR> ($)</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 64%; text-align: left">Donald J. Keyser</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 9%; text-align: right">17,667</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 9%; text-align: right">24,224</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 9%; text-align: right">41,891</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">David S. Silberstein</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">7,667</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">24,224</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">31,891</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD><FONT STYLE="font-size: 10pt">Les Kreis<SUP>(2)</SUP></FONT></TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">12,667</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">24,224</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">36,891</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">Vijay Chandru</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">7,667</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">24,224</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">31,891</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">Frank Prendergast</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">12,667</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">24,224</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">36,891</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Rule-Page --><DIV STYLE="margin-top: 0; margin-bottom: 0; width: 25%"><DIV STYLE="font-size: 1pt; border-top: Black 1.5pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">(1)</TD><TD STYLE="text-align: justify">Based on an option grant to each non-executive director of options to purchase 3,200 shares of common
stock, and a fair value of $7.57 per option share. For 2021, the fair value of each option granted was estimated using the Black-Scholes
option-pricing model using the following weighted average assumptions: term of 5.77 years, risk free rate of 1.2%, volatility of 90.69%,
and dividend yield of 0.0%. Based on these assumptions, the grant date fair value is $7.57 per option share.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">(2)</TD><TD STYLE="text-align: justify">The cash payments for Mr. Kreis&rsquo; Board service and service as Compensation Committee Chair and the
option grant for Mr. Kreis&rsquo; Board service were made to BP Directors, LP.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Effective upon the closing
of our initial public offering, our Audit Committee Chair began receiving a cash fee of $10,000 per year and our Compensation Committee
Chair and our Governance and Nominating Committee Chair began receiving a cash fee of $5,000 per year. In addition, effective November
1, 2021, each of our non-executive directors began receiving a cash fee of $46,000 per year for their Board service, $7,667 of which was
paid to each non-executive director in 2021.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 26; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->22<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in"><A NAME="a_009"></A>CERTAIN RELATIONSHIPS AND
RELATED PARTY TRANSACTIONS</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In addition to the compensation
arrangements, including employment, termination of employment and change in control arrangements discussed elsewhere in this Proxy Statement,
the following is a description of each transaction since January 1, 2020 to which we were a party or will be a party, in which:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">&#9679;</TD><TD STYLE="text-align: justify">the amounts involved exceeded or will exceed the lesser of $120,000 or 1% of the average of our total
assets at year-end for the last two completed fiscal years; and</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">&#9679;</TD><TD STYLE="text-align: justify">any of our directors, executive officers or holders of more than 5% of our capital stock, or any member
of the immediate family of, or person sharing the household with, the foregoing persons, had or will have a direct or indirect material
interest.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In May 2021, we entered into
a Collaboration Agreement with Actuate Therapeutics, Inc. (&ldquo;Actuate&rdquo;), a clinical stage private biopharmaceutical company
focused on the development of compounds for use in the treatment of cancer, and inflammatory diseases leading to fibrosis. Pursuant to
the agreement, we are collaborating with Actuate on utilization of our RADR&reg; platform to develop novel biomarker derived signatures
for use with one of Actuate&rsquo;s product candidates. As part of the collaboration, we received 25,000 restricted shares of Actuate
stock, subject to meeting certain conditions of the collaboration, as well as the potential to receive additional Actuate stock if results
from the collaboration are utilized in future development efforts. Our director Mr. Kreis is also a director of Actuate. Affiliates of
Mr. Kreis hold substantial beneficial ownership interests in both the Company and Actuate.</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">Policies and Procedures for Related Party Transactions</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Our audit committee has the
primary responsibility for reviewing and approving or disapproving &ldquo;related party transactions,&rdquo; which are transactions between
us and related persons in which the aggregate amount involved exceeds or may be expected to exceed the lesser of $120,000 or 1% of the
average of our total assets at year-end for the last two completed fiscal years, and in which a related person has or will have a direct
or indirect material interest. Our policy regarding transactions between us and related persons provides that a related person is defined
as a director, executive officer, nominee for director or greater than 5% beneficial owner of our common stock, in each case since the
beginning of the most recently completed year and any of their immediate family members. Our audit committee charter provides that our
audit committee will review and approve or disapprove any related party transactions.</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 27; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->23<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in"><A NAME="a_010"></A>OTHER MATTERS</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">Stockholder Proposals and Director Nominations for 2023 Annual
Meeting</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">For any proposal, other than
director nominees, to be considered for inclusion in our Proxy Statement and form of proxy for submission to the stockholders at our 2023
annual meeting pursuant to Rule 14a-8 of the Securities Exchange Act of 1934, it must be submitted in writing and comply with the requirements
of Rule 14a-8. Such proposals must be received by the Company at its offices at 1920 McKinney Avenue, 7<SUP>th</SUP> Floor, Dallas, Texas
75201 on or before January 1, 2023; provided, however, that if our 2023 annual meeting of stockholders is held before May 8, 2023 or after
July 8, 2023, then the deadline is a reasonable amount of time prior to the date we begin to print and mail our proxy statement for the
2023 annual meeting of stockholders. In addition, <FONT STYLE="background-color: white">pursuant to the proxy access provisions of our
bylaws, a stockholder, or group of up to 10 stockholders, that has owned continuously for at least three years shares of our common stock
representing an aggregate of at least 3% of our outstanding shares, may nominate and include in our proxy materials director nominees
constituting up to the greater of two or 20% of our Board, provided that the stockholder(s) and nominee(s) satisfy the requirements in
the proxy access provisions of our bylaws. Notice of proxy access director nominees must be received not earlier than the close of business
on December 2, 2022 and not later than the close of business on January 1, 2023. </FONT>Our Board will review any proposals from eligible
stockholders that it receives by the required date and will make a determination whether any such proposals will be included in our proxy
materials. Any proposal received after the required date shall be considered untimely and shall not be made a part of our proxy materials.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">A stockholder who wishes
to make a proposal, including director nominees other than through proxy access, at the 2023 annual meeting of stockholders without
including the proposal in our proxy statement must also notify us no later than February 6, 2023 and not earlier than January 7,
2023; provided, however, if our 2023 annual meeting of stockholders is held prior to May 8, 2023 or after August 6, 2023, then to be
timely the proposal should be received by us not earlier than the close of business on the 120<SUP>th</SUP>&nbsp;day prior to the
2023 annual meeting and not later than the close of business on the later of: (1) the 90<SUP>th</SUP>&nbsp;day prior to the 2023
annual meeting and (2) the close of business on the tenth day following the first date of our public disclosure of the date of the
2023 annual meeting. If a stockholder fails to give us advance notice in accordance with the foregoing, then, except as otherwise
required by law, the chair of the 2023 annual meeting shall have the power and duty to declare that any such nomination shall be
disregarded or that any such proposal shall not be transacted.</P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">Householding of Proxy Materials</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The SEC has adopted rules
that permit companies and intermediaries (such as banks and brokers) to satisfy the delivery requirements for proxy statements and annual
reports with respect to two or more stockholders sharing the same address by delivering a single proxy statement addressed to those stockholders.
This process, which is commonly referred to as &ldquo;householding,&rdquo; potentially means extra convenience for stockholders and cost
savings for companies.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">This year, a number of banks
and brokers with account holders who are our stockholders will be householding our proxy materials. A single proxy statement will be delivered
to multiple stockholders sharing an address unless contrary instructions have been received from the affected stockholders. Once you have
received notice from your bank or broker that it will be householding communications to your address, householding will continue until
you are notified otherwise or until you revoke your consent. If, at any time, you no longer wish to participate in householding and would
prefer to receive a separate proxy statement and annual report, please notify your bank or broker, direct your written request to Lantern
Pharma Inc., 1920 McKinney Avenue, 7<SUP>th</SUP> Floor, Dallas, Texas 75201, Attention: Investor Relations, or contact Investor Relations
by telephone at 628-777-3153; or find our materials posted online at <I>https://ir.lanternpharma.com/</I>. Stockholders who currently
receive multiple copies of the proxy statement at their address and would like to request householding of their communications should
contact their bank or broker.</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">Other Matters</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We will also consider any
other business that properly comes before the Annual Meeting, or any adjournment or postponement thereof. As of the record date, we are
not aware of any other matters to be submitted for consideration at the Annual Meeting. If any other matters are properly brought before
the Annual Meeting, the persons designated as proxies will vote the shares they represent using their best judgment.</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">Incorporation by Reference</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Notwithstanding anything
to the contrary set forth in any of our previous filings under the Securities Act, or the Exchange Act, which might incorporate future
filings made by us under those statutes, the preceding Audit Committee Report will not be incorporated by reference into any of those
prior filings, nor will any such report be incorporated by reference into any future filings made by us under those statutes. In addition,
information on our website, other than our Proxy Statement, notice and form of proxy, is not part of the proxy soliciting materials and
is not incorporated herein by reference.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="padding-bottom: 1.5pt">By Order of the Board of Directors</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    </TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 60%">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; width: 40%"><FONT STYLE="font-size: 10pt"><U STYLE="text-decoration: none">/s/ Donald J. Keyser</U></FONT></TD>
    </TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-size: 10pt">Donald J. Keyser,</FONT></TD>
    </TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-size: 10pt"><I>Chairman of the Board of Directors</I></FONT></TD>
    </TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Dallas, Texas<BR>
April 26, 2022</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>A copy of the Company&rsquo;s Annual Report
on Form 10-K for the fiscal year ended December 31, 2021 is available without charge upon written request to: Corporate Secretary, Lantern
Pharma Inc., 1920 McKinney Avenue, 7th Floor, Dallas, Texas 75201.&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"></P>

<!-- Field: Page; Sequence: 28; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->24<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"></P>



<P STYLE="text-align: center; margin-top: 0; margin-bottom: 0">&nbsp;</P>

<P STYLE="text-align: center; margin-top: 0; margin-bottom: 0"><IMG SRC="image_001.jpg" ALT="">&nbsp;</P>

<P STYLE="text-align: center; margin-top: 0; margin-bottom: 0"></P>

<!-- Field: Page; Sequence: 29 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="text-align: center; margin-top: 0; margin-bottom: 0">&nbsp;</P>

<P STYLE="text-align: center; margin-top: 0; margin-bottom: 0"><IMG SRC="image_002.jpg" ALT="">&nbsp;</P>

<P STYLE="text-align: center; margin-top: 0; margin-bottom: 0"></P>

<!-- Field: Page; Sequence: 30; Options: Last -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="text-align: center; margin-top: 0; margin-bottom: 0"></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>2
<FILENAME>image_001.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_001.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_X0 B17AI9@  34T *@    @  0$2  ,
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MU]C9VN'BX^3EYN?HZ>KQ\O/T]?;W^/GZ_\0 'P$  P$! 0$! 0$! 0
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M2:'J6K:-H^KZ+?K##<R6/VF_M(IHF25&C+HLDL3!E.U@W0@5X3_P3,_X+?\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#X!_X.>S_QI+^,7_7?0O\
MT]V%??4#?N4_W17P/_P<[6[7/_!$_P",$2_>EN-!4'W.MV&*\G/_  =X?LUQ
MMM'@?XYMMXR-$TS_ .6% S]5*\/_ ."G'/\ P3:_:$_[)IXC_P#37<U\PZM_
MP<<_#[0?V>+#XM7OP'_:=M?AGJDXMK3Q))X7TX6$S%MBG=_:&1&S_(LC (S?
M*K$\5\Z_M@_\'2O[/W[0/[)7Q2\!Z/X.^,MKK'C?PAJV@6$U[I&G1VT4]U93
M01M*RWS,J!W4L55B!DX/2@1^B7_!)'_E%;^S=_V3#PY_Z;+>N#_X**?\%-K[
M_@FW\2]+O/%^@6>H?#/Q-X4U631;ZU$O]H2>*;*/[1!I,G5-M[#N6 A=WFQ,
M#D,".\_X)(+L_P""5W[-H/4?##PY_P"FRWKUKXO? WPG\>M)TG3_ !AH.G^(
M+/0]8L_$%A'=IN%K?VDPFMYU]&1U!]""0002" ? 'QP_X*[?&SX":1XPT77/
M!O@./QYX.M_AM;7L%K9:C?6\5_XEEOHKY%@AD:>=;=K9%B2++R'=]XLH'0_%
M_P#X*]>-/V0? ?@KQ5\4O#=C>>'?'7A_Q!'IL]EX6UGP]?2>)[&8MI^DM9:A
MFXC%] '6(NH+20LP^1UQ]1?&3_@GM\(?C_K/BG4?%GA%=2U#QH^CRZQ<QZE>
M6LMS)I+S/ISJT,J&)X'N)65HRI);DG"XT+3]B+X9P?#/PWX0N?#LFM:#X0\0
M0^*=(BUO5+S5IK+4X9FGAN1/=2R2LR2,2H9R #MQMXH ^:?V#_\ @JAXZ_;(
M^/?AOX9WG@?2?#7B[P7I&K3_ !GM9/.=?"FHP7GV*QLK1PQ5S=,LURK,S@VZ
M @DL#7E_[0'_  7>^(WP2OOVDM)L_@;J'BR^^%^MZIIOA#6=/#?V)<1Z=807
MVH-JLI?=;M:V\R3X7'VA76./#JQK]#O!GP%\(_#SXB^+O%VB:#8:;XE\?3VM
MQXAU"%2LNJR6T(@@:3G'R1@*, =R<DDU@S?L<?#>X\ ?$[PN_ABW;0?C)>7F
MH>,;3[3-MUJ>[M8K2X=COW1EX(8T(C*@;<C!R: /D/XU?\%L)/A!^U1\-?"$
MVG^#5\'RZ7X?G^(^IW6H^1>^'[K7]\>FBTA9P98HYE1[@D,8X;B)LCDU:\*_
MMV_M%V?QL_:&\,>([;X(W%G^SCX;M=>UB73M.U.*36S>:/>WUO'!YERPB"36
MT:R%]VY'<C:0*^BM9_X)E? 7Q)X:\9:3JGPO\,:I;?$ !==EOH6N;J[5;6*T
M15N)&,T*I;P1(BQ.@39E0"23U&F_L=?#G2]6^(.H1^'%:_\ BKI5GHGBRYEO
M+B:76[2UM9+2".1F<D%8)I$W+AFWDL2>: /@^'_@L3\9;+]CKPG\2+_0/"\6
MI>.O$OA/1+.&7X<^*;*VT^+6(YGFDB6;$FK&+;'L^P;@_.,^9'7H'[+?_!8+
M7/B[/\$[[QAH?A/PWX9^(7@SQCXMUG5;>XF:*"WT*\A@CNH?,(,,,\+O,\4Z
M^;#PC'<IKW[P#_P2_P#@G\--#TG2]+\*ZDVFZ!J^DZ[I=I?>)M5U"#3+S2RY
ML)+=+BY=81#YC (@",-H96"J _5O^"8'P,UJTU6WN/ L/V?6HM=M[J*+4[V&
M,PZY+%+JL**DP$<5S)"C/&FU>7P '<, ?&WPS_X+Z>)?&_[&'QV\<WGA?P+8
M^./A]X=L/'_A71[;5#>6VI>'-28"S:[,<A:.[BVNEQ&"OEL\7 SBOI/_ (*<
M?ML?$/\ 8T\+>!=8\*^%;2;POK$]V?%GB^^T/4-;T_P7#%;B2&2XL[ BY\J:
M0E#.#L@"$L&W**[WX@?\$S/@/\3(YEU+X8^&X5NM!NO#%PNFQOI@NM-N)+>6
M6VE%LT?F*9+6W=2V61HP5*DG.7JG_!*GX(ZSX-_L&\\.^)+W31-/,/M'C;7)
MK@">%()X?/:\,OV>6*-%D@W>4X4;D)YH X/]O[_@I=<?LC_L/^!_B5HDW@_7
M]7\;2:<(7M!<:K:-:26YNKR_LK2)H[F_A@@1YMJM&1%F1V4(PJ#QU_P4XU/P
M_P#L8?#SXW:78^#-9\-6>OZ9I?Q8_LW4'U&U\+V\VR#4+BRO(L17*V%U-'YD
MBAXS''/A@4)'N?Q7_8:^%?QJ\"^$_#>O>$;-=)\!C9X=CTNXGTF71(OLYM6A
MMY;5XY(H7MV:%XE8))&2K*5XJQ\/OV+?AG\*_P!G'4OA#H/A6TLOAGJUM?64
M_AUIYIK(6]Z7-S;QK([&.%_-D_=H55=[;0,T ?'GP9_X*I_&C]K_ .)^E^#/
MA?X1^&NDW_C+3M9\?>'-7\5R7ZV;^#;748M,L)WAA_>2WMY,9)\*T<<-NT).
M]G .?JO_  55^/'BOPE\+]8\-^'_ (2:._C7XH2?!?5K'4X]0U!=-U^V?4DN
MKVWN8I8EN+ FP'E@1J_[XAC\AS]<?&'_ ()V?!GX\>"O".@>)O FGW%AX M%
MT_PW)97-QIMYHEJ(5A^S6]S;21SI"T:(K1!]CA%W [1C8MOV)?A78^ ?AWX7
ML_!.C:=X=^%.L0>(/">G62M:V^C7\,<T<<Z+&PW,%N)\[]P8R,S9;F@#YC\$
M_P#!0WXR:U_P4-\0?!?4=,\)C3_ UYX=T_6=0TGP1XAU2.]DO]-BN[EQ>0,]
MKIZ+(SK']L(^7!)."3ZO_P %F>/^"3?[2'_9.M;_ /2*2NTU7_@G_P#"O5_V
MB;SXK-H.J6WCK4KNSOKZ_LO$6I6<-_-:1I%;M/;17"V\VR-%4"2-AC.0<G+_
M /@H+\ M:_:F_8=^+/PU\.W&FVNO>//"NH:%83:A*\5I#-<0-$K2LB.RH"V2
M51CCH": -6?XY^#_ -G3]E_1_%WCKQ-H?A'PSI>BVCW6I:K=I:V\7[A2%W,1
MN8XP%&68\ $D"OF7_AK#X]_\%'G:S_9]\/W7P;^%5Q\LGQ8\;Z2?[3U2,]6T
M3190&8%2K)=7FV,@MB-BHST?[/G_  27TV#Q?H/CSX_>++S]H#XD>'XHUTHZ
MQ:);^%_"C(BJ/[+TA<P0R#:O^D2!YV*!MRGBOL(18;- '@G['O\ P3A^''['
MNJZAXCTVWU7Q=\2O$"C^WO'OBJ[;5/$FLM@;@UR_^IAX7$$ CA&T83(S7OP&
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "C-%-=2U %63Q!90LH>\M%\RX^RIF91OFY_=CG[_  ?EZ\=*R]0^
M*OAG1_LOVSQ%H-I]NC,MMYVH1)]H0+N+)EOF 7G(R,<UYQJ7[*EYJS*\WBZZ
MADT_6+O6M*^RZ9$J6UQ<7[79>42%S*R!A"K*8R(]X_C.,X_L/:99>%=0T6QU
MBXM]-F@N+2Q@DM=ZZ?;S6\4'D@JZ,451=*-K*0MV5!4(#0!Z]IWQ'\/ZS<+#
M9Z]HUW,PC*QPWL<C-YBEH\ -GYU4E?4 D9Q4K>-M(6^M;4ZKI@N[R%;BWA-T
MGF3Q,P571<Y92S* 1D$D#O7CVN?L66NN:OJ6I2>(M176M0"W$5ZT37#:?>QQ
MM'!<P^=(Y0QJEF2N<2-91LY9B36QXB_9#\/^)/$>GZA/<:DO]CI806$,-U<6
M\=I#9I*(E01RKMDW3.?.7#[3LSM)! /2+[QSH^F6LT]UJVEVT-O%Y\LDMW&B
MQ1EBF]B3@+N!7)XR".M30^*M-N7B$>H6$GGSFVB"W"$R2A&D,8YY8(K,5'(5
M2>@)KQ&V_84L8].MK5O%WB*15TV#2Y7!$<S0VS6YM-DRD3IY36Y?F1@TD\SD
M9D-"?L+V"S*S>(;N&&.[N+U(K6QB@6VEND,=ZT779YT3R1C.[RT*A,;3N /;
M?^$LTPVEG/\ VC8>1J(0VLGVA-ER'*JOEG.&W%T QG)91W%-L/&6DZEK#:=;
MZIIT^H1Q"=K6.Z1YEC/ <H#G:?7&*\LUW]D:'6?#7A735\0742^#;6[@TZ3[
M!"=KR8:WE9!A-UO)';N@557=#R #@=1\&_@[)\&=(_LFSU"UNM)B<R1^;8%;
MUF8'?YDXDP_S;0N4!5$5"6P& !WV<T5&DF!SG)]J=OY^Z: '44T2Y)_V>OM0
M)-P^Z: '44UGV]C3J "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "B@G%-,F#0!XC_ ,%%?V*M._X*'?L?>,/A%JFN
MW_AJU\5"T==3M(%GDLY;:[ANHV\MB ZEX5#+E25)P5."/R['_!FUIN?^3AM6
M_'P:G_R;7[9>:/I[T>90.[/S$\4?\$"OBMXS_8ITO]GO4OVM-6N/A;H[0^1I
M_P#P@%LMP\4,GFPV\EP+OS'ACDPRH3QL0$D*!7@[?\&;6F,O_)P^K<\<>#(_
M_DVOVS,JK1YPQ0%V<5^S1\#[#]F7]G/P#\-]+N[K4--\ ^';#P[:W5T )[J*
MTMXX%D?: -S",,< #). !7;TT2;OZT>=0(=131)GM0K[C0 ZBBB@ HHHH **
M** "BBB@ HHHH **** "@C-%%  !BBBB@ HHHH **** "BBB@ HHHH ****
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M4K>QF\W2XA:7"S7J+9VLD=FK*65I[J>2Y2&3 53:R JY% 'O>:,U\9_ME_\
M!2/QE^R]\:==\+Z9\/;;Q-:Z58VNJ0W45Q+NNXKM7L[: !5(\]=4:V$JD_N[
M*5Y^=AKE9_\ @J9\2[KXE3>"M/\ ASX:N-:DO-5T2TU&74IX=):_T_SKHO),
MR[4M;NP>P-O-NP;B::)B#$: /O;-&:^%?AU_P5\O/&5EXHU+5/!L/AG1]/\
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M($U=SXU_X*K:EH>F^#WT_P -:/>:EJ'A'4=;U>P2[FN%N=9M]/M+RVT&RG1
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M';3^85,;-#[-\3?VW/''@WP7\![RU^'][=:U\3DTV;7K"VL;F\@TA+B>P@N
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MVU3'\7)]5ANM+OO$N;O3+ 20:S;6"0PW4+:B]RA6)0%\R0V,9968&(DH<J7
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MO['?B!-3,Q\2):QW]S8W&H?9[J[$DL,-U<R&PW!U+0)!-'"CDAB(SE1G%6O
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MVX1R/531TC_@C!9Z2WAF;^U+>ZO/#VK0ZK)<2W,B'5Q'8Z;9^5<B*)"_RZ7
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MM]>NDMF=6Q)>7,&C0O$4PJ_V@JE&:%@_TQ^S+^U!KWQ<_:7^+'@76+;0DM?
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MM$L]-O-0U---UF^AL[@MK5O!_:J+)%O5U@MT-K$Y0N2&OL>8,*;GZ-Q2;>*
M/FS4_P!H;XF>$;OQEJS:)#XJLO#3/%'HUEIL]K<WCG5;^UMXX7/F?O# EG([
ML60K@JD>\L>G^%OQX\8>-_%&BVNH>'=/AT>^E-I->0[V:XW+J#I<KM,D<2;;
M*(-$9)#NO "ZF(";VW;@4%<B@#Y;\9?%OQU86VL:;J5C%K-]_:5]=Z/+_9$J
M3+LN[R*V>V4!X_\ 0X[6&9S)N,PN. N%$MBS_:Q\:^#S<_VEX;NM9AT[5;X7
M<:V-Q'J!TN*2YG?48ECC*21QPPBV2$+YDTVP[QN42?3F*,8H \_^ WQ0UWXG
M66J-KGAQO#=SH]U_9\D1DDD6:95WN\;.B;H2CP[6 ^\9%."AKT"C'-% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MXOX-$233K>..1[J8K-AA"9M^5*K("K9 <@'.^-?@/\7KC5/&5]I&I6']J:Q
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M8X;6.17C.=]_<J64[2E#2/A7\8;R+3=+UGQ-&UFMC:)J&H6FJ-#<7$P_L@7
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M:RKY<RQH[7LI) 7:^Y\;?V>]7^)WQX\&^)+2XT^#3-!6,W7GW#[\Q7UM=@"
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M.&N^)K.3X7^//A?X5T=+79=6_B?P3>Z[<2S[F.^.6#5+-43;M&PHQR"=W.
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MK5SX<N)]%:X#*9G%@MZDPC9=X5/M1*EE)9\'(!WU%?-?_"M?VO/^BQ?L\_\
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M^';&+X7^*O _A75H[G?>W'B;PS<Z[;SP;&&R.."^M&1]VT[B[# (V\YKRO\
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M>!/VE-,\>:7<>,OB=\%=:\,Q2EM1LM'^&^I:;?7,>U@%BN)=:G2,[MIRT+\
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M_"=X+_5O$8\77$3Z_J4EC_:PU%-3%ZEHUP;>.;[9&LNY(UR=P/RLRFU\"/\
M@GC\'/V:/&Y\2>"_ ]II>O+%=06][/>W5_)I\=U,T]Q':_:)9!;)+*S.ZP[%
M9CD@T >"?M,_\%!_BQ\.;O\ :,\7>$=+^'+?#S]F&:UAUS2M8@O'UOQ9C3+3
M5;XVUS',D-CLMKQ$AWP7'FRQMN,:D5R]U_P5Z\=Z)^T9XE\!ZIX;\(VJGXQ:
M9X(\*W?EW)_MC1VU*QL=4+CS<"_MC?6T@(PA2ZC;RR$DKZE^*W_!/3X.?&[X
MJ3>-/%'@:QU37KQK-M1)N[F&SUPV;;[0W]I'(MO?&!@#$;J.7R\#;C JQKO[
M!7PC\2ZG8WU_X'TVZO--\<#XDVLSS3^9!XA 5?MZG?PV%7*?ZL[1E* /F9/^
M"IGQ,\+?L6?"?XZ:IX'T7Q-X?\83ZEH&N:-X?MIX]2MM7DO)K71#;F29E^SS
MW,,5G*'!99;Z"0,L:2+7L7QZ_:I\>_LE_"WX'^(/'MOX.9=>UVTT/XE7.GV\
MZ6>C-<Z?=,L]FS3$K$NH1V\.9?,+)-GY3R-_P+_P30^"_P -O"UWH.C^$;R'
M0KS4K'5VTV?Q#J=U9P75E?"_MI889;AD@*70$N(@H8C#!AQ7H?[07[//@W]J
MKX1:QX#^(7A^U\3^$=>6-+_3;AW2.X$<BRIEHV5AAT5N".GUH _.*Z_X+:_&
MBQ_98USQ!>>$?AS8_$3P3X2\3>,/$NG26MZ]G9V]K8Z1=Z0BK]H$BO,NMVAD
MW,=PM[@+L."OI7[0_P#P5W\7Z!K_ ,5K7P+X>^Q6G@N\^']AILGBCP%KL>H-
M)X@U:]L;QVTUC;W5TL<=O$8%@52[EUR_ 'U!XM_X)Y_!KQSJOQ"OM4\ Z7<W
M7Q6T*V\,^*Y5GN(VU?3K>/RX;=BL@V*J +F/:Q"KDG:,7OC%^PW\+?C]?>)+
MKQ7X5_M&[\7+HZZK<1:C=VDUQ_9-Q-<Z<5>&5&C:":XF=6C*DE^2<# !\??'
M?_@K?\3OV<?$OB"UUG1/"6J:+I?PA3Q-'K,_AO4_#\D/B>YCUN;3K>ZT^[N&
MGM[*==&D@V2$3"XDA7?^^4+[5^V_^V5\0OV?/@9\-?&.@:;H^G^']<'VOQOX
MLO?#6H>([#P59C3WN?M$NGV4T5SY#2@*T_F&.W0%I 0<CT'Q)_P3C^#/C;X<
M^(_">N^"QKVA^+O#]CX8UF+5-5OKZ;4=/LKFXNK6*2>69I2T4]U/(LN_S SC
MYOE7;T/QS_8[^'_[2'@32_#'C#1M0O\ P_I$300V%KK=_IT,L+0^0\$XMIH_
MM$+1?(T4V]&!Y4T ?*WB/_@J%\0O$?Q@U/X<^"[/P%)KFH?$'4- T/7[C3K[
M4M.BT33_  KI.O7%V;2UF\^^NI6U%HX8H)(PR%#R4/F<[+_P6.\5Z!\1_!,:
MMX%\7?#[5/!M_?Z_XIM] U/P])IFLKK%WI%F#8WDS3PVQO[>.RF23+K-<(_F
M",''UEXK_P"">GP;\:>'=0TN^\":>EKJ.OP^*MUG=7-E<66J0V4%A%=6DT,B
M2V<B6EM!"/L[1@(A&/F;-'2/^":7P/T/P1J'AN'X?V,VCZMX;O/"5[#=WMW=
M->:;>7DM]<PR22RL[M)=3RS&4L9=[DAQQ@ ^;?V6O^"G?Q6_:!^-D&DWEKX3
MTO1;/P)X>\47=O9^ M<O_M5SJ7AR35)4;58[DV>G1I<(JHETI>1#L4M(RM77
M?L&?\% _BI\4O&OP;T?XK:;\/[F+X]?#A_B!X=O/"=K=V4FD-;I8O<V5Y;W$
M\Y92NH1&.X210QC=3&"0:]J\,_\ !.?X0>"_B+:^*]'\+WVEZU::7:Z,&M?$
M&I0VUQ:6MD]C;Q3VRW @G$=L[1J94=AG=G=\U7?V:/V!/A'^Q_?RWGP\\%VF
M@ZA+IL.C?;I+NYU"\BL(3F*RCFN9))([9#R(481@@';D"@#Q+_AZK&?^"JW_
M  I/[1X%_P"$):1O"'VC^T1_PD(\5BP75=A@\S_D'FR8PB3R\_:D,>_^&OGO
MPO\ \%V_B=?_ +.>F:UJWA+P'I_CAO!GBWQI=6"PW9M;NPL]"FU71;NW!GWB
M&9X9;:<%F(EM+A59,*3]]']ACX3MH4>GGP1IAAA\6_\ "=K(9)?M(UO[>=1^
MW>?O\TR?:B7P7*X.S;L^6N?U/_@F)\!]8TOP_977PWTF:W\*^%=1\$:7F>X#
M6VBW\30W=EN$@9XWC=URY9EWL5*EB2 <?^QM^U]\2/&'[0[?"_XI6O@>]U35
M? -A\1=%UGPI:W5C;FSGG^SRVES:W$T[QS)+M*2+*RRH6^5"A!\[_9W_ ."B
MWQ8\0^.OAGJGC;3OAS=?#WXP>/?%7@+38]$MKRQUGP]<:1<ZND,\YEGFBO(9
MHM(E,C(L!A:1#AU)V_3W[.O[&?PU_9.;5I? /A6WT2]UQ((M1OY+JXOK^^C@
M4I!')<W#R3/'$K,$0OM0,VT#)SR/A_\ X)>? GPOK.M:A9_#^U^W:]#JMO-/
M/J5[</9QZHTC:B+,R3-]B^TM+(9#:^46W'- 'R%X3_X+:>./CG\#OV@/$G@6
M^^#<6I?#'P]=?$OPO;S17.KKK7A.(:C&D5TD%Y$UOJ+26,4C9(6.*^@!B+'-
M>I:=^VW\;],_;1^'WPEUJ^^']PFK>$]'\6ZSJ&B_#/Q!J2W*WVL7=L;96@OI
M$TQ5M8$_TJ\+Q>87<@(NP?1/BG]@7X/^,=&L]/OO >C_ &.Q\*7_ ('BCMC+
M:#^Q+Z&*"ZL6\EEWQ/'!"!OR5,892K<U-XP_8=^&?CGXP>'?'U]H.H1^+O"M
MG9:=I]_8ZYJ%ABUL[AKFVMY8X)TCN(DF=FV3*ZMN(8,#B@#YI_9'_P""C/Q8
M\>^-O@O+\0=,^'=UX2^/FI>(='T0>'K6\LM3\/7>F&\E3[2L\\Z74,L%E+ND
MC$1CD:,;"K9'WE7S_P" ?^"7WP*^&+:X^B^ 8+6?7M,O]&GG?5+Z>>UL[YF:
M\@M)))F>S25G9F%L8LMSP0"/<O#NA6OA70;'3+&-HK+3[>.UMT:1I&2-%"J"
MS$LV !RQ)/<DT 7J*,T9H **,T9H *\K^/O@3Q)XB\:^$]7\/Z-H'B"/28]1
MM;ZQU;4&LX9H[F!8QN(AFW)E<,NWH>_2O5,TG&?_ *U 'R[\(/V2O&WPL\-_
M$+PO)J2ZCI?B#P_!ING7?V\1V\L\6@:;IGFRVYA,J.TMG(VX3.H1EX+$XM^,
M/V2_'7BSXB77B3_A)-!T^YN(7\/J(;.8WL&B/8M;-"MT) /^/E_MWE^3DRQ1
MIYFU0U?3'^>E'7_]5 '@-U\$?&'CW0OA;IMY9Z;X%7X=:VEP\V@:BDP>V31=
M1L1]E62WPB^9<Q (RY$9?D%0#'-^R_XFU#]F?P;\-Y+[P[)9V<X;Q%)J=HVI
M6^IP1.\R6[0J8/,$LIB,AW(NU'7:P? ^@2 ?_P!5+_GI0!\DZ/\ L4^/+*]T
MO5KS5M%U+Q##J/AFTU>\:XEC_P"$@TS2;ZWF\^4;6_TD?9UGC5BX5KBZB#@2
MF2NZ_9-^ WBKX;CPG=>)[70=)N?"O@BQ\',FF7CW;:PT BS<S.8XPJQF)A$F
M&(%Q,21D"O?/\]*3_/2@#XZ^&W[$_P 1/A%X=^'\=OJ4>J:AX;71FO;JWU2.
MSND2VT.ZTZ6QC+6KQM:Q3.LL9*J["ZFR04!?U/Q1\$/%$'CZ7Q5IL.DZG=:?
MX_'BRSL9KQK?[5;-X<_L=XS)Y;".16DDD P0RQJNY=Y*^YY_SBD_STH ^-/$
M7[ GCG5=%OKB/4M$%_=:7- --^U,+!;FZLM9@EE#>4'WP-J@".?EDC67,:N4
M9/:/V>O@+J_P7^+'C&5Y-.D\(W&FZ7IOAI(Y7:ZLK>WEOYI+652H41PO>>7"
M5)_<K&A ,9=_9/\ /2DX_P B@#Y6U3]B;Q;K/PQU/23X@;3;NX^'J>&$6RNE
M$%]=*]\Q2X,D#L;?%Q&,IAL&08Z5UGPY^ ?BSX>_&2SU2Q6PL;6\O]4E\07:
M:@9(M4L9M1U.\M+?[,T65GA:\C82JZ</,K>8 @KWW '_ .JCC_(H ^<M=_9(
MU@:QJOBB&6UUCQ!;^+#KFDZ=>W7EZ>+,WEO<O""L64E=K>*0,XD"RP18PN[.
M#XE_8[\8>,O'=GXJ=M%TMFU2^U>Y\/179:QE,M]H4JV\C^3N;<FE33LZ;,7$
MPR)5W%_JOC_(I<_YQ0!\U?%;]DCQ-X\M;U8;C0VWZ[JVK1174TAAN([@0M#;
MR80D1R&(QR@9PDC$!^AK>)OV5O%WQ.^,2^/KRW\.>%=8M[EK[38;:\DNFL+N
M&S2&"ZED6-!(TQ!@F50-UK&D>XY(7Z=_STHP/\B@#P+PM\$O&'P]^'_P1N+?
M3?#^M:[\-O#:Z)J&D2:@T5HLSV5O"]U:SF)CYL30-$I9%+07=QRI(5O/M"_8
M-\6^&]+@NK*X\+P:I<ZIH8U"VCDE6S?2[:>TN)+6/]WN!LY86%KN&/+,B$1F
M8LGU\>?_ -5+_GI0!\[_  H_9AU=-7^&=[XDTG3-.;P-I:Z5?P6NI&Y@UE[6
M./\ L^XD3RD#^1*]V\2N/W32[Q\V"OT,B;*-R@X_+BG4 %%%% !1110!\Q_\
M%@?VW-4_X)]_\$__ !Q\2/#]G;WWBBU%OI6A1W"[H%O[N=+>&61?XEC,GF%,
MC=LVY&<CY=\,_P#!!74O'GPWM?&'Q^_:O_:,O_'EU9C4?$-YH_C,:)HNG2,@
M>2*&+842&(D@,-BD+D)&,(O5?\'1XQ_P28UC_L;O#W_IQAKZQ_;V^"&M?M*_
ML,?%;X?>'5L6U[QKX0U#1=/%Y*8;<SSVSQIYCA6VKN89.TX':@#XVO\ _@W3
M^&.E:A86EU^TQ^U9;76JR-#90R_$T))>.J-(RQ*8<NP168A<D*I/0&LC5?\
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M4!S,_.'_ (AJ_ 7_ $<1^UQ_X<9O_C%'_$-7X"_Z.(_:X_\ #C-_\8K]'J*
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MKX:^';6.;4/VE/VKK&&6:*V22X^)?EJTLKK''&"T(!9W955>K,P R2!20?\
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M:G_:EYI%S>96VO;2Y(!7:RNS*JJ"$VMOWJT7ZPJV37YS_P#!R7\O[/?[/_\
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M_9__ .Q5B_\ 1DE?7%?(_P#P0<_Y0^?L_P#_ &*L7_HR2OKB@#\Y?^#DT_\
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M7?\ AJG]I?\ Z-1C_P##GZ9_\:H_X:I_:7_Z-1C_ /#GZ9_\:KZBHH ^7?\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MY8/BFE^!_@QJ_P#:TW@F'Q+I^@^$M!_L"^U.RO7N-(&FZG;Z-<S,(Y)R[,;
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MI>_"/X-WVFZ:S>.;-;6QT&VM+=QK]MM-C9FZMUE).<@/<3(SC WJ!P5(KLO
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M?^*;Z9M:T[^RKZ6^=;=+=X38F74K[4(98MIR'WWWES*&"S);19X+)7<?!_\
M9/C^$OC73=:AU"TEN;4:FMV\=EY,E\+MK0H&8,3B,6J@ YXVXQMY]CHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M !CU^S__ -EY\*_^C+BOT:[U^<O_  <E_P#)O?[/_P#V7GPK_P"C+BOT:S0
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M.?TH =133)A6[[>M0:=JL.KV$%U:S0W5K=1K+!-$X>.9&&596!PRD$$$<$4
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M"&A>-M-T_4-)AU@3Q3Z??A/M6G75O/);7-M(49D9HIX98RR,R-LW*Q4@GO:
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MB+QY%KW]IR:1J6KRW6EW%[JTEQ=M'*TC.BA972&!,JL(C$3!,!T#)YC^G44
M?(?@#]D/XD^!?"EK)X?U2_\ #?B*STNWTBT:?Q#<7EG&8K34H3<3QLSBX'G3
MVTJ^:'90B ;-A%>J?#/X/>+)/V:?%7AO5-8UZSUKQ#!=P6;ZK?&^FT?S+585
M"S^?++(GF*\P+2EP96 V (B^T44 ?._BCX?>,M<^&?AW2])\$7?@ZUT&8V]Y
MHV@^(X]-^VQBQEB@:"ZMVC8013M&=CB-F4!MF5$;9]I^SE\4/M]GJ5]XJUVZ
MUBW26:9H?$EW#97-TESIS0/]F#B(1>7'?YBV[")MKJYVX^F** /C/0OA?\9/
M$_PY^T:?_P )5#_;5N$U :CXMNOMDTVZ\DBN[0>=&;,*S6L;Q$@%'/[MS;H9
M=SQ?\/\ XK?"KP+=^+)-8UC5O$EO!=7<^GQZ]<S6^J7D=]8RZ=91Q8*0QS^7
M<6[M'&H5+IRPP 5^K@FTT-'N- 'ANH? CQ+X+U;X=7.B76I:QJUK>1/XLO6U
M![.TUIS'9P3WUTB3+)+.L-N1 A$L0YC9 K+)'?\ C=\)/&/Q%^)MF;'5M8L?
M"C);_:HM/UR?39&9+36%;YH65P#//IS':PW>2,Y"8/LM% 'R'K_[.WQDU;Q-
M'J1O=0;6+?29H9=2/B67[/,)?[)WV]M;AE$$S1VU_'YZ>40TROO)<M'5M/A#
M\9K_ %36=-T77_&%KK>G6L2Z9KFL:X_V/3Q):73-;RV@>6*Y96F@C$Q,[9B$
MC.7CQ)]C,-PIHBQWH ^:?#7[/_Q&\[3[Y]=\80QZ<$N++3[_ ,23$VDG]H6[
MO%*4GF^U(;>*;!N))3B=DX7:J<.W[,?QF-E)(FH>)-/OI[/3;'6+ZW\4O=7^
MK7$-OJBS7=L7FC$$7VFZMIE@,B1X0CR@%V-]H44 ?+_Q#_9A\>^(8E=]5\0:
MQ#+K/]JW]JWB:YA-P+;Q'I][9K HD5("+&&[3;&8TW,@;=@,OH'[3WPL\;?$
M9H9?!^M7VC36/AW5HK?RM2EM8WU&5[(6S2+&P#D1+>*K/N6-I0^TL%(]@HH
M^06\'>//!OQ'\(V,^J>-KZXO+[2Y;&UD\0W*R:1;KK-U-?K<QQRRPW4363Q1
MJTTDK!(L%D8(7- _9K^+DUSX7N-3OM6NM1\,W6E:@-0N_$4TK?;O[#O["Y=(
MEG\J2UBN+BWF*.D;S 7 =9?D)^O/+R>:<%VB@#Y)TS]FKXP2_#U8H_%/BRSU
M>WTG4@D=YXDF<+?R1:7#&5D2=VE1DBU)D:5@(I;G>(HR$V7(_P!G7XDW7C/P
M=+=W?B35M*T^]TN] U'Q$T0T@0:G>7%TDT*S2K=,T$MI'$SM*P%OS(A&6^JJ
M* /GOXQ>%/'GBW]J'R= ?Q!:Z;9Z5H4\%]'KLUGIMC)_:-\U[YEJN$NGEM42
M/Y@Y7,9PG#UP?B;X'?&3QC9V-UJ5GKC7VEV4NGVYLO&1LKI9FTJ" 78FC(/E
MM>1M(R;LD$.R,P\NOKXQY;KWSBG4 ?*^@?L]?$[PJTL=U-?ZGH,FM7-_?:9H
MVO/I-QJ(GU7Q#=,\;HZ>7N^W:9(Z"5-RQ,A9O+V2>B?M4>#OB!XM_P"$=A\$
M^9 EN\MQ<W,&JRV4T-PKP>0&"RJDD#)]HWAUF^98E"8=V7V2B@#YM\.?"3XD
M6FH^'9-47Q-=O9S7BZY+%XMF6'4M1>2!K75HHO/4)9(%NMUA\J 7$:^5+Y2L
MN9X=^%WQH\*Z9:W4,FM7<EO!;PWFG77BMKF34+_^SM1ANKY)I"1';27,VGLL
M "!/LSR+"C?(_P!2T4 ?*VN_LN_$36_!%]'JVIZYK=YJ"S27EHOBR\BCG,-Y
MI\]HD)$B"%MD%R-R;,F4AR0Q-:6J? GXL7%YJVJVOBO5M,U:%MNBO)K4T]C9
MI)?:JTCS6N?*G9;6XL@%D5\&! A!3<?I>@C- '@?[%-IJNJZ)XV:^_X2>/0;
MR_M8]+&I^(+O5) HTVU6Y,-S.1+L-QYOS*?O[V&UBRKQ/A#]E3XG>&?ACI.@
M0ZYK.GQ>'_#@M;".T\3W("WJ:';VT09BQ9XTO!.X#DKG:Q4\ ?6(7'>EH \+
M^"OP-\9?#OXQMJ5YK6O7V@21WT#07_B.ZU%%1HM-^S$1S.PW"6*_8M]X><1N
MVE47%^*7[/\ XO3QEXLU30U\07>G>)-5DO9;'3O%]UIEQ-(-*MK>VF67S,0Q
MQ31S!HH\*P:-RDAC5:^CJ* /-?V>/AAXB\&^!=0C\9:UJ&M>(]6U"]EO;K^T
M)FA,1GE$'V="V+9?)*'9%MVDGDD UX3X _9%^)G@/X=:6GA_4M0\.^(K/0;'
M1 9_$4]Y;QM!I%Y;-*Z,[+-_I;VSH\@9U15P$V[1]@44 >'^'O@KXFU']D7Q
M?X3UB\UV^UCQ#8:C;6T6IZFQN+3SH61(1=)-)*8]^6#F4N!)CY0H4<EXM^"'
MQ9L#'!X9U35(YH[*_L+1[GQ!-]AL(GL%C@D/[PR/<K.F%:6.9 KLWRN Q^G:
M* /DGXK? ?XI?$!/[.T73]5T7P]-H^HZ<]GJ?BN?47N([C2]2C"W32W$RR2_
M;Y+-U95.V)03*<>4GK'[1MMXFO\ XB_#NQ\,ZAJ5K_;6H3:?JRP2R1PP:<!%
M=3W)*C E'V5;>-B05-^Q'&ZO7J0KS0!\=:9\"_C[IWPKTW3Y]:UC4/$B_O[V
M]?77C5-3A@@59X#]I/\ H5Q(;EWBD4JA2)5M5$CNOLT7PG\::/\ LP^,-%TS
M6]07QUK4>KS6-_>:K-=&VN)I)OLVR1R3$B1F%55 %CVY SDGV"B@#YM\*? #
MXC6VH6NI-XB\5H]F=,:QM=0U^5ELE_M.]DOHYHEGECN!]DE@16FDF8JBC<&0
M&N1\#?LT_%W3['4S)>ZWIMSJ=I86E]<2^+IKJ\O)HHH$N+A)22\2,WVAD4.-
MNXD+&6VC[ HH ^1_%'@GQYX$\>>&]+_MGQ1J$TVO6/\ 9$5MXCOF^QZ?'XFG
MGN3=+RMTKZ0\$9,Y<HMLRY5F#2?6Z'*TGE9&,G'I3@-HH ;(NY:^.?AM\7M<
M_8V^,7QLTOQ#\*/BYX@@\8>.YO%6BZEX7\/_ -L6-]93Z?8PKF2*3,4BRVTR
M-'*$8;5;E'5C]D4TQY:@#Q7_ ()S?##Q!\&/V(OAKX9\5:;)HOB+3=&3^T-/
M>:.9[&5W:0PN\;,C.F_:Q1F7<#@D8->V4U8@AS3J $89%?(GAKXLZS^QW^T;
M\=HM<^%OQ7\2:?\ $+QG;>+-$U3PKX?.LV5Q:'0-'TYT<Q/OAF2XT^<&.15R
MIC9=P;CZ\/--V<T >%_\$VOA]X@^&7['OAO3?%&BW?AW6[J_UC6)M+NWC>YL
M$OM6O+V&*;RV=!*L5Q&'"LP5@PR<9KW:FK%M-.H 1_N5\>)X^U[]D7]MOXW:
MYK/PS^*'BCP_\3)-#U'1-3\)Z'_;,!%KIRVD\4RQOYD,B21YPZ@,KJ5+88+]
MB$9%-\N@#P3_ ()O^!/$'@C]GK5)O$FAZAX9U#Q9XX\5^+8-+U'RQ?65GJFO
M7U_:I<+&[K'-]GN(BT>XE&)5L,I ]]IHCP13J /SE_X.3?\ DWK]G_\ [+SX
M5_\ 1EQ7Z-=Z_.7_ (.3!G]GK]G_ /[+SX5_]&7%?HU0 4444 %%%% 'YV?\
M'2'_ "B8UC_L;O#W_IQAK]#[7_CVC_W1_*OSP_X.D/\ E$QK'_8W>'O_ $XP
MU^A]K_Q[1_[H_E0!)5._\1Z?I6HVEG=7UG;7=^2MM!+.J27)'4(I.6QD=,]:
MN5XS^U7\,=;^*VM>#K+2-+N95T[6;'4I[V0V(T]8H+V">2.X,@-X#MBW1_9=
MN95C$C>7N! /9J*IZ+J-QJ6GQ37-G)I\TF=UO*Z.\>"0,E"R\@ \$]:ML<&@
M");RW:Z> 2PF:-5=XPPWJI)"DCK@E6P>^T^E06.OZ?J5_<6EM>V=Q=69VSPQ
M3*\D!]&4'*_C7S1XZ^ 7Q8N/B!XJ\9:+<:#;:KXJ74M'FCMII+:^@TQ5_P!
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M\>VOB31%U"QN1'JNG/X:T.S%S!(L9211<V5U$VUB5>%@P'&0#Z@^"?QC\/\
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MM%OEWF*_F<;7RB['Q;^%/Q*^(_Q;^(@\.W&N:0K P:9JIUZXM;=(GT)XC!#
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** /SE_X.3/^3>O
MV?\ _LO/A7_T9<5^C5?G+_P<F?\ )O7[/_\ V7GPK_Z,N*_1K- !1110 444
M4 ?G9_P=(?\ *)C6/^QN\/?^G&&OT/M?^/:/_='\J_/#_@Z0_P"43&L?]C=X
M>_\ 3C#7Z'VO_'M'_NC^5 $E%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 ?G+_P<F\_L]?L_P#_ &7GPK_Z,N*_1KO7YR_\')?_ ";W^S__ -EY
M\*_^C+BOT:H **** "BBB@#\[/\ @Z0_Y1,:Q_V-WA[_ -.,-?H?:_\ 'M'_
M +H_E7YX?\'2'_*)C6/^QN\/?^G&&OT/M?\ CVC_ -T?RH DHHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@#\Y?^#DS_ )-Z_9__ .R\^%>G_72X
MK]&@:_.7_@Y,_P"3>OV?_P#LO/A7_P!&7%?HU0 4444 %%%% 'YV?\'2'_*)
MC6/^QN\/?^G&&OT/M?\ CVC_ -T?RK\\/^#I#_E$QK'_ &-WA[_TXPU^A]K_
M ,>T?^Z/Y4 24444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110!^<O_
M  <F?\F]?L__ /9>?"O_ *,N*_1KO7YR_P#!R:/^,>OV?_\ LO/A7_T9<5^C
M7>@ HHHH **** /SL_X.D/\ E$QK'_8W>'O_ $XPU^A]K_Q[1_[H_E7YX?\
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M8:_0^U_X]H_]T?RH DHHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M-ZY\,/&6N3:U>%='T&QM](T+SMZ1M*UM!+J5PJLWS0O/#&8^%*[)\</D@'T
M7Q_":/,S_":^1?@C^QSXST'6?#'B6XO_  'JTZZ['KWVNU,36,$$MO:I=R6M
MI'8QPM+<^2[I,C0RP&09FN$::.;6^+_P.U+Q!\6/&VMWU[9V7A.TOM)GL+#7
MKE[72=:O+@VL=];2,-P,$JVMA'&1&1Y\]V&242LA /J3>?[M DR/N_A7R3JO
M[+/BZ_\ !MOH=GXN\+V^E^+K:5K6=-5N@897T[4HXK*R15_>6\<=Q$ZRAU;R
M[0GRNC)ZA\=_V8M(\;_#[P[I/EZ+IOAGPC9WA^S3[H[2W)L9(89<#Y1Y+L)0
MS<H4#KAP" #V;S./NFCS#_=-?*NB_L,^*M?^*-WJWBW4_"^JZ/J&H0W&H6D5
MNOEZY#!-N@-RB6\9ED6']VQN)+@N=S!D1S$M.3_@GSX@T[P[X=L+/6=/:RT]
M;4ZA:PW1M#<W8L;>";4EGEMKDB[66%I$D"+*3*6\Y&&2 ?3C?$/28]!?5&O(
M1I\=X=/>?G8LXN/LQ3..TWR$] 0<G )K9$I(^[^1KY6U3]F/7SK5QIT8\-QW
MVL>&=1\/N]Q>++J%S:O?E1=0Q&(- D27$4TICG*R,PC:'?Y<J[W[8'[.?C3X
MM^+X=:T&\TA;/1-%N8[6-88UU4W#V]W'+&DODF4K*);<#9<P!#&VX2;QL /H
MPR$?PF@.?[IKXN'[$GC.YN;73QI'A73K;5],U=H_(O9VLO!-U-!H-O#>VF8P
MTE\LEE=WB@)%^\GE'GJQ>69?'_[!7C36O!7B[PY;^(_#/]I^,+J>7[3?RP2/
M>JJWABU 1-I[>3=PR7<)=P9I7$4:K<P!$% 'V%>^);/3]8L=/FF2.\U+S#;0
MG.Z41J&<CCHH(R3QD@=2 :-W\3-#L?#EYJ\VH0QZ;I]R]I<3D-B&9)O)9",9
MR)/EZ<Y!'!S7S_\ $3]BJ^U72=4CM;'2=<N/$4NN27WGWGV19'N]9M]0M6EE
MDM[D,D<-M'"T3V\T;B.*,IY6ZMC1?A!<?$;]GSX@6VI:]X9NF\7ZE&]Y=Z?F
M+38Q96]G8W! 21S&KFPE?9O)B$BQLQ:-F(!]"&3T7F@.?[IZU\CQ?L:7WB;Q
M3-JGA_Q1HDWAY8=1L=(33M06WC\.F:74)(XH0EM([1NE[ DD44]L +6/_6@(
MJU=+_8S:P\4W%YINN^%[S2=>ALXM$LCJ216>L6\:V-U)I4L*VK/);R1V=Q()
M?/D55NI6^S-YDID /L+S#_=-8_B7XA:+X-D9=6U.QTYDL;G4V^T3"/%K;>7Y
M\QS_  1^;'N/;>*\)\!?L7ZKX5U^QUZ:[T5=<TS4+6YTXPO,RZ+9"\O9YM-M
MW*@K!]GNDM@0BAT@3<BA$1>Z^.GP5U3XQVG@^9;C3=-OM+OE&L(2\L5UI\T>
MR]M8VV@G>0A5F4 ^6,@9H [+2_BYX;UWQ!8Z58ZUI][J&J6/]IVD-O*)3/:D
M*1,"N1L8.I!SAL\9YKHMY_NU\NM^P#?:C;W2ZKJ6BZE)!#J]MHPE@D*:5$\%
MM;Z3L'7=;);M(6'*RS,8\84B+P;^Q5)KGCGQ$WB#5-'\36;>*7OM5@ENUN([
MY'BOI8H;JT6VCVS1QZA: &>:X+10Q$>6 B@ ^I9[G[/"\C [8P6/? '/:FV-
M_'J-E#<0[FAN$61"5*DJ1D9! (X/0@&O!_&_[.VNZYX0^$NDI?Z#?>*/!EK
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M2^&M.6'Q3#-I_A:VL#';ZE8-?C68=.LX89KF:1SYMHMQ'>F3+.S&2$A60,%
M/0]._9EUW3?A#H&EW$<5Q?:'XUM/$7DV.J2VWF01RJ& =2FXB,LWEO\ (VT
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M/PG8:YJ:^-+Y+Z;3;'3-2TT6]GIS:1J(@:ZM>723^TDB87!00_/;)YN[S(F
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% 'YR_\')G_)O7[/\
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M ,!T_P * *'_  M;PO\ ]#)H'_@PB_\ BJ/^%K>%_P#H9- _\&$7_P 55_\
MX1/2O^@9I_\ X#I_A1_PB>E?] S3_P#P'3_"@"A_PM;PO_T,F@?^#"+_ .*H
M_P"%K>%_^ADT#_P81?\ Q57_ /A$]*_Z!FG_ /@.G^%'_")Z5_T#-/\ _ =/
M\* *'_"UO"__ $,F@?\ @PB_^*H_X6MX7_Z&30/_  81?_%5?_X1/2O^@9I_
M_@.G^%'_  B>E?\ 0,T__P !T_PH H?\+6\+_P#0R:!_X,(O_BJ/^%K>%_\
MH9- _P#!A%_\55__ (1/2O\ H&:?_P" Z?X4?\(GI7_0,T__ ,!T_P * *'_
M  M;PO\ ]#)H'_@PB_\ BJ/^%K>%_P#H9- _\&$7_P 55_\ X1/2O^@9I_\
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M_P (-HO_ $!]+_\  2/_  H_X0;1?^@/I?\ X"1_X4 9?_"[O!?_ $-WA?\
M\&L'_P 51_PN[P7_ -#=X7_\&L'_ ,56I_P@VB_] ?2__ 2/_"C_ (0;1?\
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M (6MX7_Z&30/_!A%_P#%4?\ "UO"_P#T,F@?^#"+_P"*J_\ \(GI7_0,T_\
M\!T_PH_X1/2O^@9I_P#X#I_A0!0_X6MX7_Z&30/_  81?_%4?\+6\+_]#)H'
M_@PB_P#BJO\ _")Z5_T#-/\ _ =/\*/^$3TK_H&:?_X#I_A0!0_X6MX7_P"A
MDT#_ ,&$7_Q5'_"UO"__ $,F@?\ @PB_^*J__P (GI7_ $#-/_\  =/\*/\
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MH_\ ='\J_/#_ (.D/^43&L?]C=X>_P#3C#7Z'VO_ ![1_P"Z/Y4 25S>@?\
M)3/$'_7E8_SN*Z2N;T$?\7+U\]OL=ES^,] '24444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %<CHW_ "7CQ)_V -)_]*-2KKJY'1@?
M^%[^)#V_L'2AG_MXU*@#KJ*** "BBB@#A?CO_P @[PQ_V,VF_P#H\5W5<+\=
MP3IOAG Z>)M-SQT_?BNZ!R* "BBB@ HHHH **** "BBB@ HHHH **** "N5T
MW_DMFM?]@/3_ /T?>UU5<MIJM_PNK6FP=O\ 8FGC/;_7WM '4T4"B@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ KD]'_ .2Y^(O^P%I7
M_I1J-=97)Z.#_P +R\1'M_86EC/_ &\:C0!UE%%% !1110!PG[1?_)/]/_[&
M?P]_Z>K*N[KA/VB_^2?Z?_V,_A[_ -/5E7=T %%%% !1110 4444 %%%% !1
M110 4444 ?G+_P ')G_)O7[/_P#V7GPK_P"C+BOT:K\Y?^#DS_DWK]G_ /[+
MSX5_]&7%?HUWH **** "BBB@#\[/^#I#_E$QK'_8W>'O_3C#7Z'VI_T:/_='
M\J^1?^"Z7[(_BC]M7_@FGXZ\'^";;^T/%UC)9Z_I5@" =2FLKB.X^SJ3QOD5
M&5 < N5!(!->2_"#_@YS_9?NOAWI@^)OB?6?A/X^MX4M]>\+:[X=OQ=Z5>HH
M6:/,<+J4$@8*20V,;E0Y4 S]&&&17R3^W#^RW\,_CG^T/X/D\=>%]?N)M3T^
M2Q76H?B)X@\,6@$,C.EI'%ILJQ3W;>9(ZK-Y;N@(1I-C*G!_\1-'[$>/^2W6
M?_A/ZK_\C5R_C_\ X."/V"OB=?Z=-K/QNEN(--FCN$LTT_6X;.:6.5)HGEA2
M )(T<D:.I8'!44!9A9?L6_L@O8V4L^B_&AH[Z)1;W-I\1/'%Q:WESFU1[:%Q
M?AFD$EY"F&1<DN!S%*$T-8_8(_9+T>QT^1]!^,#7&J)>I;VG_"U/%:W+75HU
MPDUGY9U8-YHDM9XPP!B+(/WF'0MY3I7_  6'_8!T_P")UIJS?'*S70=)A5=-
MT:#0]>2*"4-9.)G+*REPUC$<QI'O)8OO)8GI+G_@M?\ \$Y[KQ@=<D^+"M?/
M*T\@%AKHAFD:>]N-SQB':V)-1O2 1@>>0!@+@%9G9Q_L&?LB0?#RU\1:AI'Q
MBTZ&> 22VC_$KQI-=6TGV&*^:%DBU)MSK#,GW-P+94$D5=\#?\$[?V3/B-XB
MUC1])TWXI-J^BV]S/+:S?%GQ:C,;:7R+E01JAP8;C]R^<?-]W<OS5YK!_P %
MG/\ @G+%/:L_Q@NKA;.!((XIK?7Y(AMMX[;S"ABP9###$A<C)" ]<D]3X6_X
M. OV"?!EUKCZ7\;I;6/Q!+/<7%L=-UJ2VBFGD>6:2*)H"D;22R/(VT %F8XY
M- 69PWA/]E3X":GJ M;SX<^.[AH(=)6Z>P^.'C)KB"6^M-.N?,D@:\VQ6X_M
M 1(YF9WDCQL4-D>B3?\ !/']F_2OB=\1]+U/PSXTL=#^&UHUU>WG_"[O&3ZA
M,J6-I>,XMOM8C6(+<[-WV@MNC^YALCD_#'_!<#_@G_HOP?G\'W7QN^U0:@EB
M=0NH-)UJUFNI[.WM;>&=2D.8G"6=O_JR!E,]SES?\%M_^">=S=W\EY\:M0U2
M'5I;6XU"TOH=?N+74)K<6RQ2S0M$4D<+:6X)8'>$PV0S9 LS8\/_ + GP!UP
M^!X[CX?^/]&F\0WMSI&L/J'QS\7K:Z1J5M.L$EA#-'>.MQ.[^8T D\@3H@((
M9M@L?"S_ ()W_ CXG?LR7/Q"M_ 'CZ\N!;I<VVD:/\;?&NHR%7BBDVRL;F-U
MD02DND,4Q"H=GF,0APV_X+<_\$ZH[P-:_%B'3;-M7AUV73;#2]:M-/N+V'[.
M8IGMXX%C8HUI P&W;N3<02S9TO!7_!?/]@KX>_#>3PKI/QYU:WTGRE@@WPZ]
M+<6,:HJ)'!,\)>)550 %( _$T#LR&Q_8/^ .OWMKI>B^!_%>KZQ>VMO>PSP?
M'WQA_8OD-%/--,;O[49-D:PJHVP,S23*I5%5Y%JK^QU^S1'J]Q:-X.\?7L)T
MS2KW3]1TSXY^++K3M5FNKCR;B"*4WZ'-NK)("RJ95\S"KY4FVK!_P6J_X)U6
M5C'':_&"XLKJ&9;J/4+:UUZ._2<-<,TPG$7F;Y#=W)D)/[SSGW;LTX?\%J_^
M"<;:!%ILOQ4AN((;NQOU>;3]=>8W%G,TT,ID,._=O>3?SB19'5]RL5(%F=5\
M4O\ @GI^SM\+_&TVB3^ _BG=30ZWIEFTB_&?Q8BIIMW&[RZFV=1^6.W,%T)$
M_NP;MP# #G8?V%?@KXGU*%?#OPR\9W=G/XBAT2*XU+X^^,[,W$5Q&9K6\C6.
M>;*2P 2!6*D!T'<XT?''_!>C_@GO\1_$EYJ^L?%JUN]0U#P_=>%IY1I.M1[]
M.N65IH=JP!<L5&' WKR%8!CF+1?^"[O_  3S\.I9K8_%BSMTL+BRNH%71]9V
MQR6=N+:W(!@_@A 7'0XR<GF@+,S],_90_99UJ/PZEGX1^)EQ?:PDC7ELGQH\
M7;]+*ZI9:?AC_:&&RUWOXQQ$1SN!'1?LU?L!_LX_M#P^'4_X07XJZ#J.KZ$^
MKWUI-\9O%<SZ7*K6V("5U(!P\5U%,D@P&CDC; W\9,G_  72_P""=\NEZ'9-
M\5[4V_AQ'33U_LK6_P#1PUU!=-SY.6_?6T+?-G[F.A(,_@3_ (+Q?\$]?AIX
MHM=:T7XL6=CJ-IH5MX;CD&D:RP^PVY_<QE6@*LRX \PC>P506(50 +,YKX&?
ML@_ S]H'PMH9T/X8^-6\1>()8C!:O\??&8TZ&!M/COG>2Y,XE#HLL<11;=@9
M'P'(5V3IO"O[!W[/?BCQCX8\.?\ "N_BE9:UXM\S['%)\:O%;QQ&SGEM]6\Q
MAJ. ;22(!0,_://BV%0)3%SF@?\ !9;_ ()S^%O#5CING?&;4K-],>%[._1?
M$/\ :%H(8&MHHTN#&9!&L+O&(\[,,202<UJ:9_P7$_X)VZ!;VWV#XK6-O-I\
MEE-9SMI.MR2VSV9<P;7,._&Z6<R#=^^-S/YA;S7W K,]9^!__!(']G_XI_!O
MPKXEO/#OQ&L[K7M*MK^:"'XN^+VCB>2-695)U/.T$\9YQ74_\.1/V=_^@+\3
M/_#M^+O_ )9UY!\*/^#BO]A[X5_#'P_X9A^.UO>1>'].@T];B3P]J:M,(HPF
MX@6V!G&<#@9KH/\ B)I_8C_Z+=9_^$_JO_R-0%F=_P#\.1/V=_\ H"_$S_P[
M?B[_ .6='_#D3]G?_H"_$S_P[?B[_P"6=<!_Q$T_L1_]%NL__"?U7_Y&H_XB
M:?V(_P#HMUG_ .$_JO\ \C4#LSO_ /AR)^SO_P! 7XF?^';\7?\ RSKQSX^?
M\$P/@-\+_%MY'9?#+QWXDL]$\.R^(]7GD^-WBZUO$LX)&5DMHC>.DTH&]@LD
ML*Y.-W)(Z3_B)I_8C_Z+=9_^$_JO_P C5P_Q)_X+O?\ !/GXM:^FHZ[\8VN9
M/L3:;/#%8Z[;VU_:L^\P7$4<*I-&6SE7!!!8$$$@@69K:]_P3H_9%TGQ1)HM
MMX.^+&J:G#J&F64D-I\5/$[[([ZZ6UCN6_XFWRQ([#<'VOC:0A# G<^!_P#P
M2Y_8[_:*L+ZZ\*:9\0-0AL3$9#_PM3Q:I:.9/,AE _M/[DB?,N<-CJ%/%>=V
MG_!;+_@G7I^K:A?0?%^2*ZU&^_M%V%GKN(9O[2.J,8U\G;&&O"TK!0 Q8J<K
M\M=-\,O^#A3]@WX1>'8](T7XW/'IMOA;:WN-,UFY6SC50JQ1>9 Q2-5  4'
M H"S/6/^'$_[-/\ T+/Q"_\ #J^+/_EE1_PXG_9I_P"A9^(7_AU?%G_RRKB_
M^(FG]B/_ *+=9_\ A/ZK_P#(U'_$33^Q'_T6ZS_\)_5?_D:@-3UOX-?\$A_@
M/\ /BCHWC+POX>\86_B#P_,UQ8RW_P 0?$6J01.R-&6:WNKZ2&3Y7;&]&P2"
M,$ CZ6086O@[_B)I_8C_ .BW6?\ X3^J_P#R-1_Q$T_L1_\ 1;K/_P )_5?_
M )&H"S/O*BO@W_B)I_8C_P"BW6?_ (3^J_\ R-1_Q$T_L1_]%NL__"?U7_Y&
MH"S/O*BO@W_B)I_8C_Z+=9_^$_JO_P C4?\ $33^Q'_T6ZS_ /"?U7_Y&H"S
M/O*BO@W_ (B:?V(_^BW6?_A/ZK_\C4?\1-/[$?\ T6ZS_P#"?U7_ .1J LS[
MRHKX-_XB:?V(_P#HMUG_ .$_JO\ \C4?\1-/[$?_ $6ZS_\ "?U7_P"1J LS
M[RHKX-_XB:?V(_\ HMUG_P"$_JO_ ,C4?\1-/[$?_1;K/_PG]5_^1J LS[RH
MKX-_XB:?V(_^BW6?_A/ZK_\ (U'_ !$T_L1_]%NL_P#PG]5_^1J LS[Q8;EK
MY5_;K_9?^&_QV^-OP_\ ^$Y\,ZW>2:E')I4>M1?$+7?"MG;*)D*6H&G2K'/=
M2M*YB2;9O\ME63/RUYQ_Q$T_L1_]%NL__"?U7_Y&KF?B!_P<(_L&_$ZYTQM8
M^-TLT&EW,=VEK%IVM0VMQ)'(DL9FB2 ++LDC1@'!&1Z$@@K,CA_8Q_8^MM,M
M;B\TGXQ>5-:K*]U9_$3QS<V9G^R1WC6Z.+X.T@@EC8 H-V_:/G5U7;F_X)[?
MLFVI\/K-H?Q>MI?$-_<Z5!%-\5O%<<L-[!.]L]LZ'5@VXSH8E9 T98J=^UU8
M^/#_ (+ _P#!/Z3XCV>I-\;[.'P[IMOLM]&@T/7D5YOLL5J)I6961F$,2J&2
M-&("[F;;SU,__!;G_@G7-XN76Q\7/*OC>1:A+Y5AKJ17$\5]/?Q/(@AVOLN;
MFXD4$;096&,8  LSI?"O[$'[(>O?!O3?&=YH_P 8='L[[3X+Z:UG^)WC&:XL
M_,TD:MY3"'4G#,MJ<G86!;Y02Q K8\"?\$[_ -D7XB>-K[P[96/Q3M]:T^SE
MO9[6Z^*OB^.2)(#"MRK#^U"0T+W$*N#CYGPI;:^WR[3_ /@L5_P3?TW2[&QC
M^+<[:?IUDMA!:O;Z^T 1;)[!69/*PT@M',(=LMM"\Y4$=KX6_P"#@S]@OP9X
MCUC4M-^-GD-KLKW%W:MI>LO9F9R#)*L+0;$9R,L5 W$DGEB2!9D>C_L&?LTR
MZAHMOJ'@CXN1R^)M'LM7TB"S^+7B^YNKW[8;V2*V\H:D )4M;-Y9"6V+AP&(
M4%K5A^PU^R'>7%NT>G_%B\M-0E4VUS9_$SQO)'';E+ B:<M?IY7S:C; K\Q
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M?>H> Y/#<GQE==,;4FU>#R]/UR.>PNC.;@203+")(MLI) 1@ &9<;25.3/\
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M]T%K-IFLSPV2\XBA5X#Y<8R<(N !@     69ZS_PXG_9I_Z%GXA?^'5\6?\
MRRI?^'%'[-/_ $+/Q"_\.MXL_P#EE7%?\1-/[$?_ $6ZS_\ "?U7_P"1J/\
MB)I_8C_Z+=9_^$_JO_R-0%F>J?"K_@CQ\ O@I\2-%\6>'O#GC&/7/#]TM[8R
M7WQ#\1ZE;QS+]UFM[F_DADP>0'1@" <9 -?3J9"\U\'?\1-/[$?_ $6ZS_\
M"?U7_P"1J/\ B)I_8C_Z+=9_^$_JO_R-0%F?>5%?!O\ Q$T_L1_]%NL__"?U
M7_Y&H_XB:?V(_P#HMUG_ .$_JO\ \C4!9GWE17P;_P 1-/[$?_1;K/\ \)_5
M?_D:C_B)I_8C_P"BW6?_ (3^J_\ R-0%F?>5%?!O_$33^Q'_ -%NL_\ PG]5
M_P#D:C_B)I_8C_Z+=9_^$_JO_P C4!9GWE17P;_Q$T_L1_\ 1;K/_P )_5?_
M )&H_P"(FG]B/_HMUG_X3^J__(U 69]Y45\&_P#$33^Q'_T6ZS_\)_5?_D:C
M_B)I_8C_ .BW6?\ X3^J_P#R-0%F?>5%?!O_ !$T_L1_]%NL_P#PG]5_^1J/
M^(FG]B/_ *+=9_\ A/ZK_P#(U K,Y?\ X.3?^3>OV?\ _LO'A7_T9<5^C0/-
M?D+^UC^VEX9_X+M_M"_ WX0_L\VNN>,/!_@CQ[IWC[QOXX?2I[/2-%MK$LT=
MNKS*K--+ND 4J,L$V[AYC1_KPC9)H =1110 4444 !&X5AZY\,O#GB>_-UJ7
MA_1-0NF 4S7-A%-(0.@W,I-;E% '+_\ "D?!O_0H^%__  50?_$T?\*1\&_]
M"CX7_P#!5!_\37444 <O_P *1\&_]"CX7_\ !5!_\31_PI'P;_T*/A?_ ,%4
M'_Q-=110!R__  I'P;_T*/A?_P %4'_Q-'_"D?!O_0H^%_\ P50?_$UU%% '
M+_\ "D?!O_0H^%__  50?_$T?\*1\&_]"CX7_P#!5!_\37444 <O_P *1\&_
M]"CX7_\ !5!_\31_PI'P;_T*/A?_ ,%4'_Q-=110!R__  I'P;_T*/A?_P %
M4'_Q-'_"D?!O_0H^%_\ P50?_$UU%% '+_\ "D?!O_0H^%__  50?_$T?\*1
M\&_]"CX7_P#!5!_\37444 <O_P *1\&_]"CX7_\ !5!_\31_PI'P;_T*/A?_
M ,%4'_Q-=110!R__  I'P;_T*/A?_P %4'_Q-'_"D?!O_0H^%_\ P50?_$UU
M%% '+_\ "D?!O_0H^%__  50?_$T?\*1\&_]"CX7_P#!5!_\37444 <O_P *
M1\&_]"CX7_\ !5!_\31_PI'P;_T*/A?_ ,%4'_Q-=110!R__  I'P;_T*/A?
M_P %4'_Q-'_"D?!O_0H^%_\ P50?_$UU%% '+_\ "D?!O_0H^%__  50?_$T
M?\*1\&_]"CX7_P#!5!_\37444 <O_P *1\&_]"CX7_\ !5!_\31_PI'P;_T*
M/A?_ ,%4'_Q-=110!R__  I'P;_T*/A?_P %4'_Q-'_"D?!O_0H^%_\ P50?
M_$UU%% '+_\ "D?!O_0H^%__  50?_$T?\*1\&_]"CX7_P#!5!_\37444 <O
M_P *1\&_]"CX7_\ !5!_\31_PI'P;_T*/A?_ ,%4'_Q-=110!R__  I'P;_T
M*/A?_P %4'_Q-'_"D?!O_0H^%_\ P50?_$UU%% '+_\ "D?!O_0H^%__  50
M?_$T?\*1\&_]"CX7_P#!5!_\37444 <O_P *1\&_]"CX7_\ !5!_\31_PI'P
M;_T*/A?_ ,%4'_Q-=110!R__  I'P;_T*/A?_P %4'_Q-'_"D?!O_0H^%_\
MP50?_$UU%% '+_\ "D?!O_0H^%__  50?_$T?\*1\&_]"CX7_P#!5!_\3744
M4 <O_P *1\&_]"CX7_\ !5!_\31_PI'P;_T*/A?_ ,%4'_Q-=110!R__  I'
MP;_T*/A?_P %4'_Q-'_"D?!O_0H^%_\ P50?_$UU%% '+_\ "D?!O_0H^%__
M  50?_$T?\*1\&_]"CX7_P#!5!_\37444 <O_P *1\&_]"CX7_\ !5!_\31_
MPI'P;_T*/A?_ ,%4'_Q-=110!R__  I'P;_T*/A?_P %4'_Q-'_"D?!O_0H^
M%_\ P50?_$UU%% '+_\ "D?!O_0H^%__  50?_$T?\*1\&_]"CX7_P#!5!_\
M37444 <O_P *1\&_]"CX7_\ !5!_\31_PI'P;_T*/A?_ ,%4'_Q-=110!R__
M  I'P;_T*/A?_P %4'_Q-'_"D?!O_0H^%_\ P50?_$UU%% '+_\ "D?!O_0H
M^%__  50?_$T?\*1\&_]"CX7_P#!5!_\37444 <O_P *1\&_]"CX7_\ !5!_
M\31_PI'P;_T*/A?_ ,%4'_Q-=110!R__  I'P;_T*/A?_P %4'_Q-'_"D?!O
M_0H^%_\ P50?_$UU%% '+_\ "D?!O_0H^%__  50?_$T?\*1\&_]"CX7_P#!
M5!_\37444 <O_P *1\&_]"CX7_\ !5!_\31_PI'P;_T*/A?_ ,%4'_Q-=110
M!R__  I'P;_T*/A?_P %4'_Q-'_"D?!O_0H^%_\ P50?_$UU%% '+_\ "D?!
MO_0H^%__  50?_$T?\*1\&_]"CX7_P#!5!_\37444 <O_P *1\&_]"CX7_\
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E%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 ?_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>image_002.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_002.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_X0 B17AI9@  34T *@    @  0$2  ,
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MU]C9VN'BX^3EYN?HZ>KQ\O/T]?;W^/GZ_\0 'P$  P$! 0$! 0$! 0
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M,\4 %%)O'K2YH **,\T YH ***"<4 %%%)O'K0 M%(77UH#J>] "T44;AF@
MHH#!NE&: "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH ****  \BO@GP[_P5A\0?#[XU_%+PUXD\)ZYX
M\NE^-!^&'@C2_#-O:0W(SH$>IIY\EQ/%'M++*&E9@$# D;5-?>QZ5\VVO_!,
M#X?V/QK;Q[#JGB]=:?XDM\4C&;N VS:H=(?23%M\G=]F^SN6V!@^_!W[?EH
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M.;?1;ZYTK0M;T'Q+<7]OJFK)I40ADTZ_GA6YBN''F6\LB. R%=X8&JO[1_\
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M^'?_  G7CJ__ .$FMK^";Q'))8VNM6;7<;1F6W-K:Q6T3P@@Q;8-JE5)#<Y
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MW7C:\U+Q9XTLY+L:_H.B21VFEZW?0Q011WUU;&ZG^SQ(L<5NKN_E-N(8KO\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M1F@ HHS1F@ HHS1F@ HHS1F@ HHS1F@ HHS1F@ HHS1F@ HHS1F@ HHS1F@
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M4!S,_.'_ (AJ_ 7_ $<1^UQ_X<9O_C%'_$-7X"_Z.(_:X_\ #C-_\8K]'J*
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M?^'&;_XQ7Z/44!S,_.'_ (AJ_ 7_ $<1^UQ_X<9O_C%'_$-7X"_Z.(_:X_\
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MU?@+_HXC]KC_ ,.,W_QBC_B&K\!?]'$?M<?^'&;_ .,5^CU% <S/SA_XAJ_
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M[QE=^&]/L[A[37&M))X9[6*,6Q$2/*BOLW8;<3D# !^B\7[#?P4MV?R_@_\
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M<LLD:@&&/RG!((QL()X-?.'Q>4/_ ,&^&M+QC_A01ZCC']@5^;_P1FO/A_\
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M3EF/H'[-/[0WQR^'/_!3'X1_!WQK\=M$^,OAGQK\,;_QM>W5KX;T_39S<>9
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M _2.FI*'./QYK\\_'G_!3_XZ>*O$OC#X9Z?^SSI+>,O _@:7Q/\ $2TB^(*
M>'8KM[M;&SL9UM"MY>/:PK<'<(8PQ,8<8#UZ+_P1T^*R^%_^"*7P=\:>*M4O
M;JWTGP,=6U34+F1KB9HH1+))(S,2S':A/)STH ^R2<4TRX[&OS\^&'_!9OQ[
MK5E\&_%WC3X'6/@_X4_M%:O#X?\  6N+XR%]J"WUW'(^EIJ5HMHHMX[T1_*\
M4DQBW ,IS7)?\$*CXX^+O[2_[4OQ,^(&@1GQ GQ,\0^$)=7'CJ^U1-,6SNH
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M ! \3>,+7Q[\%-3\<ZGL@TNW-A>6\FA)%<6A$"1PQJNK2&1YR\*B))&  <L
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M\ >%=-\.:CJD?E7TJ)>Z@=7@@C>Y!AO)-.D2U9FG1V#QH9QEF"P?LY0Z=>^
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MGPQ=ZK:/&_@%Y)O$DTEEI@LM4OM%BNX91<)LU&V-P,DR[)UBB5U>/O+_ /9
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M2;FX\1^&FA7PWIS'4989K&[DF<V,\"W"6\EN[2R7$<5LIVNC2GR_XD?!77/
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M]!\16NK>#[FZU#Q-9-K&C>&7B74M"NX;N#2[<:HMT8Q;VMK-8>5;"!&AGTX
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MBMI^M6WAV'5+G4%OK75K+7+:'3=/B3.!(^F7@L&G+*&E2RNK@9>\*@ _0[<
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ML38)&Y74J<$C(KU"@#\Y?^#DP?\ &/?[/_\ V7GPK_Z,N*_1JOSE_P"#DO\
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M21^&M-\4Z/XZT+2@([W5)]+73K[3+R21&^U0(\T$S+=)+!+"NZ.6R8[D8HU
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M/7/A9ITNDR:]I^H:7I'@O5_ V@2S[WNHK&>\\ZR68[0O[F 1PL$X/DJ0!G
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MRR30O<1PRW 1I3^]:*)2RLB@J@=K_C?]E#XB_'+2?$EQXJN/ ^@ZQ-\.-0\
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M I?$+]K'1_AE^T#X<\!ZUIMU:/XJDCMM-U ZEIY%Q,ZN5"VGVC[88]T90R"
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MUKX<"/Q)JDVA_#&Y.IZ9;S6MN;^>_>.X2XN);U4$F+AKB22:.,(LC<<1DQD
MY;X5?\%#]2\;_"CX>WT_PJ\9:CXT\:>"QXVFT319]/F2WLE,*2.DTETL;%C-
M&8HB_FN'P54I+LZ(?\%!O"NILNK:/H_B37/ %O/IEIJ7C&WC@CTW2YM0@MI[
M59(994NV3RKZR:22.!DB%TNXCRKCR>/\/?L)>+?!/CSPA8>'?B!KVBZ#X/\
M -SX/L];MX+-KPP/=P&*%X7C*--%!"FRX"C#J258.R'J(O\ @G=H&CVTGA_1
M_$6N:1\-]0N=+O-4\)Q1P26]])IUO:VT"_:'0SI%)%8VBS1ACYGDGE/,E\P
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MS9Q&1')&Y#8PKJ>A%7-2\06>CV'VJ\NK6UM=R()II5CC+.P5!N)QEF90!W+
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M)/  IVG:C#JMG#<6\T5Q;W$:RQ2Q,'25&&0RL.""""".#F@"<C-&**:[;!0
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M>1E>",9+"1V^QL';^G2N?^(OQ$T[X6Z%:ZEJGVC[->:KI^D(8(][>?>WD-E
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MI]TK;;<6RH)I56%Y#$DQC9)=AK[[VG^]1L]Z /S+UG3+CX*_!SQGJEO;3_\
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M6FO:=:0P37,L%S=I>6[W:LLL4IA>T()(W+$NUB8L+]ET$9H ^&/V@OV4M?\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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ME\M,G:FYS@9.!W->O4 ?G+_P<E_\F]_L_P#_ &7GPK_Z,N*_1JOSE_X.2_\
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M!\;>-/CQXN\*:3XMTG6M<_M#0_$<&N*&O8;2QP(;-K+<\D;6ZQE%MG$FX%J
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MGYA7DG_!2/\ ;Z\1?&#QIH/Q"^&^N?&J/P1J'[.\WQ%MH? GBB+38O#UW_:
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M[PMK\^EO/<6^FW,D(E>$CSH-VUC&<JQ53VKX_P!)^(GQ&_9LM?V$]0\*ZO\
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MBR]BFO!81.9([*WAMXH;6VMUD9Y-D,*9=B23@8_.JU^,?Q%G_P""4<?[9_\
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M'@WX_>#O WA/X@37IN-5LX-7@@EFTZZN% -V+.>;8_F$R,C!7)P* /M?P_\
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M?)<2\^9YS[U8L#O&1P,?G/\ $N;P+JW[$?A&33[CX">(/@WI_P ;-*G^,:_
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MBC4O#C>$;J_G0R/<:2TS3-9LI.TQ-(S,1C)SR<<5^:O_  2-^-OPS^ /QO\
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M GN35FV_9Y\%V?Q"\7>+(O#]E'XB\>:?;:5K]^"WFZI:VZRI#%)SC:BS2@8
M/SFNSHH \XTG]D7X;Z'HGPUTVU\)Z?#8_!XJ?!L0:0C0-MJ]HOE$MDXMW>/Y
M]W!]<&N0_9S_ ."9OP*_9&^(=UXL^&WPXT7PGX@O+::TFN[.6<L\4L@DD3:\
MC* S@,<#J*]VHH \G\2?L,_";Q=I7B:RU'P3I=U;^,?$EMXOU@%Y5:\U>W\G
MR;TL'#+*GV>'!0@?(..3G"\#_P#!-'X%_#3]HNZ^+6@?#K1]+^(E]J%YJMQK
M4,T_G2W5YYGVF4H9/+W2>;(3\O5NW%>ZT4 >9>!_V-?A?\--6^(U_P"'_!>B
MZ3>?%ZX>Z\936\;*_B"5UD5FF.>I$LOW<<R.>K$UYQX#_P""0'[-GPR\%>(O
M#>A_";P_I^A^+([&+5K)9[EXKU;*Y2ZM00TIQY4\:.-N.5 .0,5]*44 >*_%
M?_@G5\%?C?JWC._\4^ =+U2^^(5SIEYXAN#-/#)J<^FQ/#93,T<BE9(8I'0.
MFUBI )(  P?&_P#P2:_9R^(OPM\'^"=6^$GA6;PKX!-T?#^FP1R6L.FM<E6N
M&7RG4LTK(K.S$EVR2222?HBB@##^&WPXT7X0_#[0_"OAS3X=*\/^&[*'3=-L
MXF9DM;>) D<8+$L0J@#DD\=:W*** /SE_P"#DO\ Y-[_ &?O^R\^%?\ T9<5
M^C5?G+_P<E_\F]_L_P#_ &7GPK_Z,N*_1J@ HHHH **** /SL_X.D/\ E$QK
M'_8W>'O_ $XPU^A]K_Q[1_[H_E7YX?\ !TA_RB8UC_L;O#W_ *<8:_0^U_X]
MH_\ ='\J )*CFM8[DIYD:2>6P=-RYV,.A'H>3S4E% #?)4DY4-GKD=:#"I7;
MM&W&,8XQ]*=10 Q8$7[JJN>N!C-*(57HH7G/ [TZB@"-+:.-W9556D.YR!@L
M<8R?7@#\J/LL>U1M7"_=X^[]*DHH :858J=O*\@^E(;=&5E*KANO'WOK3Z*
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH _.7_@Y+_P"3>_V?_P#LO/A7_P!&7%?H
MU7YR_P#!R8?^,>_V?_\ LO/A7_T9<5^C5 !1110 4444 ?G9_P '2'_*)C6/
M^QN\/?\ IQAK]#[7_CVC_P!T?RK\\/\ @Z0_Y1,:Q_V-WA[_ -.,-?H?:_\
M'M'_ +H_E0!)1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% 'YR_\
M')?_ ";W^S__ -EY\*_^C+BOT:K\Y?\ @Y,_Y-[_ &?_ /LO/A7_ -&7%?HU
M0 4444 %%%% 'YV?\'2'_*)C6/\ L;O#W_IQAK]#[7_CVC_W1_*OSP_X.D/^
M43&L?]C=X>_].,-?H?:_\>T?^Z/Y4 24444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MZ<8:_0^U_P"/:/\ W1_*@"2BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** /SE_X.2_\ DWO]G_\ [+SX5_\ 1EQ7Z-5^<O\ P<EG_C'O]G__ ++S
MX5_]&7%?HU0 4444 %%%% 'YV?\ !TA_RB8UC_L;O#W_ *<8:_0^U_X]H_\
M='\J_/#_ (.D/^43&L?]C=X>_P#3C#7Z'VO_ ![1_P"Z/Y4 24444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110!^<O_!R7_P F]_L__P#9>?"O_HRX
MK]&J_.7_ (.2_P#DWO\ 9_\ ^R\^%?\ T9<5^C5 !1110 4444 ?G9_P=(?\
MHF-8_P"QN\/?^G&&OT/M?^/:/_='\J_/#_@Z0_Y1,:Q_V-WA[_TXPU^A]K_Q
M[1_[H_E0!)1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MU)Y@]Y<P6ILE*"6R"2"5V=5]W_X+*?MJ^-/V+M7^'^NZ=XXM?"7PWA2\N?&
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M!M(=X@FQF!5>2"?E'H,?'7_$33^Q'_T6ZS_\)_5?_D:C_B)I_8C_ .BW6?\
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MQ'_T6ZS_ /"?U7_Y&H"S/O*BO@W_ (B:?V(_^BW6?_A/ZK_\C4?\1-/[$?\
MT6ZS_P#"?U7_ .1J LS[RHKX-_XB:?V(_P#HMUG_ .$_JO\ \C4?\1-/[$?_
M $6ZS_\ "?U7_P"1J LS[RHKX-_XB:?V(_\ HMUG_P"$_JO_ ,C4?\1-/[$?
M_1;K/_PG]5_^1J LS[RHKX-_XB:?V(_^BW6?_A/ZK_\ (U'_ !$T_L1_]%NL
M_P#PG]5_^1J LS[RHKX-_P"(FG]B/_HMUG_X3^J__(U'_$33^Q'_ -%NL_\
MPG]5_P#D:@+,^\J*^#?^(FG]B/\ Z+=9_P#A/ZK_ /(U'_$31^Q'_P!%NL__
M  G]5_\ D:@+,Y?_ (.3!_QCW^S_ /\ 9>?"O_H=Q7Z- YK\A?VL?VT/#/\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
8* "BBB@ HHHH **** "BBB@ HHHH __9

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
